{"protocolSection":{"identificationModule":{"nctId":"NCT01165177","orgStudyIdInfo":{"id":"110390"},"secondaryIdInfos":[{"id":"2008-000367-42","type":"EUDRACT_NUMBER"},{"id":"2008","type":"NIH","link":"https://reporter.nih.gov/quickSearch/2008"}],"organization":{"fullName":"GlaxoSmithKline","class":"INDUSTRY"},"briefTitle":"Study to Evaluate Efficacy, Safety and Immunogenicity of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 50 Years and Older","officialTitle":"Efficacy, Safety, and Immunogenicity Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged 50 Years or Older"},"statusModule":{"statusVerifiedDate":"2021-01","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2010-08-02","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2014-05-09","type":"ACTUAL"},"completionDateStruct":{"date":"2015-07-27","type":"ACTUAL"},"studyFirstSubmitDate":"2010-07-15","studyFirstSubmitQcDate":"2010-07-15","studyFirstPostDateStruct":{"date":"2010-07-19","type":"ESTIMATED"},"resultsFirstSubmitDate":"2016-07-28","resultsFirstSubmitQcDate":"2017-03-21","resultsFirstPostDateStruct":{"date":"2017-05-01","type":"ACTUAL"},"dispFirstSubmitDate":"2013-08-22","dispFirstSubmitQcDate":"2013-08-22","dispFirstPostDateStruct":{"date":"2013-08-30","type":"ESTIMATED"},"lastUpdateSubmitDate":"2021-01-25","lastUpdatePostDateStruct":{"date":"2021-02-10","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"GlaxoSmithKline","class":"INDUSTRY"}},"descriptionModule":{"briefSummary":"The purpose of this observer-blind study is to evaluate the efficacy, safety and immunogenicity of GSK Biologicals' candidate Herpes Zoster (HZ) vaccine in adults aged ≥ 50 years.\n\nTwo studies \\[ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229)\\] are being conducted concurrently to evaluate efficacy of GSK1437173A vaccine. A pooled analysis of data from both studies combined will be conducted contingent on each study achieving its objectives. The protocol posting of study ZOSTER-022 also deals with the outcome measures related to the pooled analysis.","detailedDescription":"This protocol summary has been updated following Protocol Amendment 4 changes to study objectives and endpoints and the analyses of the objectives in 2 steps.\n\nStep 1 will include analyses of the following objectives of ZOSTER-006 (NCT01165177): all HZ VE objectives and all reactogenicity/safety and immunogenicity objectives. At step 2, all objectives of study ZOSTER-006 (NCT01165177) will be analyzed. Objectives already analyzed at step 1 will be re-analyzed (confirmatory descriptive in case of inferential analysis at step 1 or descriptive analysis otherwise). At step 2, pooled analyses of studies ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229) are planned; overall PHN VE in subjects ≥ 70 YOA, and other pre-specified endpoints will be analyzed."},"conditionsModule":{"conditions":["Herpes Zoster"],"keywords":["subjects 50 years and older","vaccine","immunogenicity","efficacy","Herpes Zoster","safety"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE3"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"PREVENTION","maskingInfo":{"masking":"TRIPLE","whoMasked":["PARTICIPANT","INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":16165,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"GSK1437173A group","type":"EXPERIMENTAL","description":"Subjects will receive Herpes Zoster Vaccine GSK1437173A according to a 0, 2-month schedule","interventionNames":["Biological: Herpes Zoster Vaccine GSK1437173A"]},{"label":"Placebo group","type":"PLACEBO_COMPARATOR","description":"Subjects will receive NaCl solution placebo according to a 0, 2-month schedule","interventionNames":["Biological: Placebo"]}],"interventions":[{"type":"BIOLOGICAL","name":"Herpes Zoster Vaccine GSK1437173A","description":"Intramuscular injection","armGroupLabels":["GSK1437173A group"]},{"type":"BIOLOGICAL","name":"Placebo","description":"Intramuscular injection","armGroupLabels":["Placebo group"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Number of Subjects With Confirmed Herpes Zoster (HZ) Cases","description":"Confirmed HZ cases during the study were assessed in the Modified Total Vaccinated Cohort (mTVc)","timeFrame":"During the entire study period (3 to 5 year period following Day 0)"}],"secondaryOutcomes":[{"measure":"Number of Subjects With Any Episodes of Post-Herpetic Neuralgia (PHN)","description":"The incidence of PHN was calculated using the modified total vaccinated chort.","timeFrame":"During the entire study period (3 to 5 year period following Day 0)"},{"measure":"Number of Subjects With a Reduction of Duration of Severe 'Worst' HZ-associated Pain","description":"Severe 'worst' pain was defined as HZ-associated pain rated as 3 or above on the 'worst pain' Zoster Brief Pain Inventory (ZBPI) questionnaire. The outcome assessed the duration of severe 'worst' HZ-associated pain following the onset of a confirmed HZ rash over the entire pain reporting period as measured by the ZBPI in subjects with confirmed HZ. This analysis involved any subject reporting clinically significant pain (i.e. pain with a score of 3 or more on a 0-10 point scale) at any time during the study.","timeFrame":"During the entire study period (3 to 5 year period following Day 0)"},{"measure":"Number of Subjects With Confirmed HZ Episode Related Mortality","description":"The analysis focused on the number of subjects who died due to HZ","timeFrame":"During the entire study period (3 to 5 year period following Day 0)"},{"measure":"Number of Subjects With HZ Related Complications","description":"The analysis focused on the incidence of HZ complications in subjects with confirmed HZ","timeFrame":"During the entire study period (3 to 5 year period following Day 0)"},{"measure":"Number of Subjects With Confirmed HZ Episode Related Hospitalizations","description":"The analysis focused on confirmed HZ episode related hospitalizations.","timeFrame":"During the entire study period (3 to 5 year period following Day 0)"},{"measure":"Number of Subjects With a Confirmed HZ Episode Having a Reduction of Duration of Pain Medication Associated With HZ","description":"The analysis focused on patients who experienced a reduction in duration of pain medication administered for HZ in subjects with confirmed HZ.","timeFrame":"During the entire study period (3 to 5 year period following Day 0)"},{"measure":"Number of Subjects With a Confirmed HZ Episode Taking Pain Medication Associated With HZ","description":"The analysis focused on subjects taking pain medication due to HZ","timeFrame":"During the entire study period (3 to 5 year period following Day 0)"},{"measure":"Number of Days With Severe 'Worst' HZ-associated Pain.","description":"Severe 'worst' pain was defined as HZ-associated pain rated as 3 or above on the 'worst pain' ZBPI questionnaire. This Outcome Measure was only assessed participants with confirmed HZ. This analysis involved any subject reporting ZBPI clinically significant pain (i.e. pain with a score of 3 or more on a 0-10 point scale) at any time during the study.","timeFrame":"During the entire study period (3 to 5 year period following Day 0)"},{"measure":"Number of Subjects With Confirmed HZ Episode Related Mortality and Hospitalizations","description":"The analysis focused on confirmed HZ episode related hospitalizations and deaths.","timeFrame":"During the entire study period (3 to 5 year period following Day 0)"},{"measure":"Number of Subjects With HZ Related Complications, by Complication Type","description":"Complication types included HZ vasculitis, Disseminated Disease, Ophtalmic Disease, Neurologic Disease, Visceral Disease and Stroke. This Outcome Measure was only assessed participants with confirmed HZ.","timeFrame":"During the entire study period (3 to 5 year period following Day 0)"},{"measure":"Distribution of Pain Medication Associated With HZ","description":"The distribution of pain medication included 1 to 3 or more separate medications. This Outcome Measure was only assessed on participants with confirmed HZ.","timeFrame":"During the entire study period (3 to 5 year period following Day 0)"},{"measure":"Number of Days of Pain Medication Associated With HZ","description":"The analysis was performed on subjects with a confirmed HZ episode","timeFrame":"During the entire study period (3 to 5 year period following Day 0)"},{"measure":"Number of Subjects With Any and Grade 3 Solicited Local Symptoms","description":"Assessed solicited local symptoms were pain, redness and swelling. Any = occurrence of the symptom regardless of intensity grade. Grade 3 pain = Significant pain at rest that prevented normal activity. Grade 3 redness/swelling = redness/swelling spreading beyond 100 millimeters (mm) of injection site. Relationship analysis was not performed.","timeFrame":"During the 7-day (Days 0-6) post-vaccination period"},{"measure":"Number of Subjects With Any, Grade 3 and Related Solicited General Symptoms","description":"Assessed solicited general symptoms were fatigue, GI (gastrointestinal) symptoms (included nausea, vomiting, diarrhoea and/or abdominal pain), fever \\[defined as oral, axillary, rectal or tympanic temperature equal to or above 37.5 degrees Celsius (°C)\\], headache, myalgia, shivering and sweating. Any = occurrence of the symptom regardless of intensity grade. Grade 3 symptom = symptom that prevented normal activity. Grade 3 fever = temperature\\> 39.0 °C. Related = symptom assessed by the investigator as related to the vaccination.","timeFrame":"Within the 7-day (Days 0-6) post-vaccination period"},{"measure":"Number of Subjects With Any and Grade 3 Symptoms (Solicited and Unsolicited)","description":"Number of subjects with any and grade 3 solicited and unsolicited symptoms were tabulated","timeFrame":"Within the 7-day (Days 0-6) post-vaccination period"},{"measure":"Number of Subjects With Any and Related Potential Immune Mediated Diseases (pIMDs)","description":"Occurrence and relationship to vaccination of any potential immune-mediated diseases (pIMDs) in all subjects","timeFrame":"During the entire study period (3 to 5 year period following Day 0)"},{"measure":"Number of Subjects With AEs With Any and Related Medically Attended Visit","description":"Occurrence and relationship to vaccination of medically attended visits (defined as hospitalizations, emergency room visits or visits to or from medical personnel), other than routine health care visits in all subjects.","timeFrame":"From Month 0 to Month 8 post-vaccination"},{"measure":"Number of Subjects With Unsolicited Adverse Events (AEs)","description":"Occurrence, intensity and relationship to vaccination of unsolicited AEs, according to the Medical Dictionary for Regulatory Activities (MedDRA) classification in all subjects An unsolicited AE covers any untoward medical occurrence in a clinical investigation subject temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product and reported in addition to those solicited during the clinical study and any solicited symptom with onset outside the specified period of follow-up for solicited symptoms. Any was defined as the occurrence of any unsolicited AE regardless of intensity grade or relation to vaccination. Grade 3 AE = an AE which prevented normal, everyday activities. Related = AE assessed by the investigator as related to the vaccination.","timeFrame":"Within 30 days (Days 0 - 29) after each vaccination"},{"measure":"Number of Subjects With Serious Adverse Events (SAEs)","description":"Occurrence and relationship to vaccination of all SAEs in all subjects. Serious adverse events (SAEs) assessed include medical occurrences that result in death, are life threatening, require hospitalization or prolongation of hospitalization or result in disability/incapacity.","timeFrame":"Within the 30-day (Days 0-29) post-vaccination period, up to Month 14 and up to study end (3 to 5 year period following Day 0)"},{"measure":"Number of Subjects With SAEs Related to Study Participation or to a Concurrent GSK Medication/Vaccine","description":"The number of subjects with SAEs related to study participation or to a concurrent GSK medication/vaccine were tabulated","timeFrame":"During the entire study period (3 to 5 year period following Day 0)"},{"measure":"Number of Subjects With Fatal SAEs","description":"Number of subjects with fatal SAEs during the entire study period were tabulated","timeFrame":"During the entire study period (3 to 5 years following day 0)"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Subjects who the investigator believes will comply with the requirements of the protocol;\n* Written informed consent obtained from the subject;\n* A male or female aged 50 years or older at the time of the first vaccination;\n* Female subjects of non-childbearing potential may be enrolled in the study;\n\nFor this study population, non-childbearing potential is defined as current tubal ligation, hysterectomy, ovariectomy or post-menopause.\n\nOR Female subjects of childbearing potential may be enrolled in the study, if the subject has practiced adequate contraception for 30 days prior to vaccination, and has a negative urine pregnancy test on the day of vaccination, and has agreed to continue adequate contraception during the entire treatment period and for 2 months after completion of the vaccination series;\n\nExclusion Criteria:\n\n* Use of any investigational or non-registered product other than the study vaccine within 30 days preceding the first dose of study vaccine, or planned use during the study period;\n* Concurrently participating in another clinical study, at any time during the study period, in which the subject has been or will be exposed to an investigational or a non-investigational product;\n* Any confirmed or suspected immunosuppressive or immunodeficient condition resulting from disease or immunosuppressive/cytotoxic therapy;\n* History of HZ;\n* Previous vaccination against varicella or HZ;\n* History of allergic disease or reactions likely to be exacerbated by any component of the vaccine. Additionally, consider allergic reactions to other material or equipment related to study participation;\n* Significant underlying illness that in the opinion of the investigator would be expected to prevent completion of the study;\n* Receipt of immunoglobulins and/or any blood products within the 90 days preceding the first dose of study vaccine or planned administration during the study period;\n* Administration or planned administration of any other immunizations within 30 days before the first or second study vaccination or scheduled within 30 days after study vaccination. However, licensed non-replicating vaccines may be administered up to 8 days prior to each dose and/or at least 14 days after any dose of study vaccine;\n* Any other condition that, in the opinion of the investigator, might interfere with the evaluations required by the study;\n* Acute disease and/or fever at the time of enrollment;\n* Chronic administration of immunosuppressants or other immune-modifying drugs within six months prior to the first vaccine dose.\n* Pregnant or lactating female;\n* Female planning to become pregnant or planning to discontinue contraceptive precautions.","healthyVolunteers":true,"sex":"ALL","minimumAge":"50 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"GSK Clinical Trials","affiliation":"GlaxoSmithKline","role":"STUDY_DIRECTOR"}],"locations":[{"facility":"GSK Investigational Site","city":"Mesa","state":"Arizona","zip":"85213","country":"United States","geoPoint":{"lat":33.42227,"lon":-111.82264}},{"facility":"GSK Investigational Site","city":"Phoenix","state":"Arizona","zip":"85018","country":"United States","geoPoint":{"lat":33.44838,"lon":-112.07404}},{"facility":"GSK Investigational Site","city":"Phoenix","state":"Arizona","zip":"85020","country":"United States","geoPoint":{"lat":33.44838,"lon":-112.07404}},{"facility":"GSK Investigational Site","city":"Phoenix","state":"Arizona","zip":"85050","country":"United States","geoPoint":{"lat":33.44838,"lon":-112.07404}},{"facility":"GSK Investigational Site","city":"Tucson","state":"Arizona","zip":"85704","country":"United States","geoPoint":{"lat":32.22174,"lon":-110.92648}},{"facility":"GSK Investigational Site","city":"Spring Valley","state":"California","zip":"91978","country":"United States","geoPoint":{"lat":32.74477,"lon":-116.99892}},{"facility":"GSK Investigational Site","city":"Vista","state":"California","zip":"92083","country":"United States","geoPoint":{"lat":33.20004,"lon":-117.24254}},{"facility":"GSK Investigational Site","city":"Clearwater","state":"Florida","zip":"33761","country":"United States","geoPoint":{"lat":27.96585,"lon":-82.8001}},{"facility":"GSK Investigational Site","city":"DeLand","state":"Florida","zip":"32720","country":"United States","geoPoint":{"lat":29.02832,"lon":-81.30312}},{"facility":"GSK Investigational Site","city":"Jacksonville","state":"Florida","zip":"32205","country":"United States","geoPoint":{"lat":30.33218,"lon":-81.65565}},{"facility":"GSK Investigational Site","city":"Jacksonville","state":"Florida","zip":"32216","country":"United States","geoPoint":{"lat":30.33218,"lon":-81.65565}},{"facility":"GSK Investigational Site","city":"West Palm Beach","state":"Florida","zip":"33409","country":"United States","geoPoint":{"lat":26.71534,"lon":-80.05337}},{"facility":"GSK Investigational Site","city":"Meridian","state":"Idaho","zip":"83642","country":"United States","geoPoint":{"lat":43.61211,"lon":-116.39151}},{"facility":"GSK Investigational Site","city":"Overland Park","state":"Kansas","zip":"66212","country":"United States","geoPoint":{"lat":38.98223,"lon":-94.67079}},{"facility":"GSK Investigational Site","city":"Wichita","state":"Kansas","zip":"67207","country":"United States","geoPoint":{"lat":37.69224,"lon":-97.33754}},{"facility":"GSK Investigational Site","city":"Baltimore","state":"Maryland","zip":"21209","country":"United States","geoPoint":{"lat":39.29038,"lon":-76.61219}},{"facility":"GSK Investigational Site","city":"Columbia","state":"Maryland","zip":"21045","country":"United States","geoPoint":{"lat":39.24038,"lon":-76.83942}},{"facility":"GSK Investigational Site","city":"Kansas City","state":"Missouri","zip":"64114","country":"United States","geoPoint":{"lat":39.09973,"lon":-94.57857}},{"facility":"GSK Investigational Site","city":"Las Vegas","state":"Nevada","zip":"89104","country":"United States","geoPoint":{"lat":36.17497,"lon":-115.13722}},{"facility":"GSK Investigational Site","city":"Las Vegas","state":"Nevada","zip":"89119","country":"United States","geoPoint":{"lat":36.17497,"lon":-115.13722}},{"facility":"GSK Investigational Site","city":"Edison","state":"New Jersey","zip":"08817","country":"United States","geoPoint":{"lat":40.51872,"lon":-74.4121}},{"facility":"GSK Investigational Site","city":"Somers Point","state":"New Jersey","zip":"08244","country":"United States","geoPoint":{"lat":39.31762,"lon":-74.5946}},{"facility":"GSK Investigational Site","city":"Cary","state":"North Carolina","zip":"27518","country":"United States","geoPoint":{"lat":35.79154,"lon":-78.78112}},{"facility":"GSK Investigational Site","city":"Charlotte","state":"North Carolina","zip":"28209","country":"United States","geoPoint":{"lat":35.22709,"lon":-80.84313}},{"facility":"GSK Investigational Site","city":"Hickory","state":"North Carolina","zip":"28602","country":"United States","geoPoint":{"lat":35.73319,"lon":-81.3412}},{"facility":"GSK Investigational Site","city":"Salisbury","state":"North Carolina","zip":"28144","country":"United States","geoPoint":{"lat":35.67097,"lon":-80.47423}},{"facility":"GSK Investigational Site","city":"Wilmington","state":"North Carolina","zip":"28401","country":"United States","geoPoint":{"lat":34.23556,"lon":-77.94604}},{"facility":"GSK Investigational Site","city":"Winston-Salem","state":"North Carolina","zip":"27103","country":"United States","geoPoint":{"lat":36.09986,"lon":-80.24422}},{"facility":"GSK Investigational Site","city":"Cleveland","state":"Ohio","zip":"44122","country":"United States","geoPoint":{"lat":41.4995,"lon":-81.69541}},{"facility":"GSK Investigational Site","city":"Wadsworth","state":"Ohio","zip":"44281","country":"United States","geoPoint":{"lat":41.02561,"lon":-81.72985}},{"facility":"GSK Investigational Site","city":"Carnegie","state":"Pennsylvania","zip":"15106","country":"United States","geoPoint":{"lat":40.40868,"lon":-80.08339}},{"facility":"GSK Investigational Site","city":"Pleasant Hills","state":"Pennsylvania","zip":"15236","country":"United States","geoPoint":{"lat":40.33563,"lon":-79.96061}},{"facility":"GSK Investigational Site","city":"Uniontown","state":"Pennsylvania","zip":"15401","country":"United States","geoPoint":{"lat":39.90008,"lon":-79.71643}},{"facility":"GSK Investigational Site","city":"Greer","state":"South Carolina","zip":"29650","country":"United States","geoPoint":{"lat":34.93873,"lon":-82.22706}},{"facility":"GSK Investigational Site","city":"Mt. Pleasant","state":"South Carolina","zip":"29464","country":"United States","geoPoint":{"lat":32.79407,"lon":-79.86259}},{"facility":"GSK Investigational Site","city":"Bristol","state":"Tennessee","zip":"37620","country":"United States","geoPoint":{"lat":36.59511,"lon":-82.18874}},{"facility":"GSK Investigational Site","city":"San Antonio","state":"Texas","zip":"78229","country":"United States","geoPoint":{"lat":29.42412,"lon":-98.49363}},{"facility":"GSK Investigational Site","city":"Murray","state":"Utah","zip":"84123","country":"United States","geoPoint":{"lat":40.66689,"lon":-111.88799}},{"facility":"GSK Investigational Site","city":"Arlington","state":"Virginia","zip":"22203","country":"United States","geoPoint":{"lat":38.88101,"lon":-77.10428}},{"facility":"GSK Investigational Site","city":"Norfolk","state":"Virginia","zip":"23502","country":"United States","geoPoint":{"lat":36.84681,"lon":-76.28522}},{"facility":"GSK Investigational Site","city":"Richmond","state":"Virginia","zip":"23294","country":"United States","geoPoint":{"lat":37.55376,"lon":-77.46026}},{"facility":"GSK Investigational Site","city":"Winchester","state":"Virginia","zip":"22601","country":"United States","geoPoint":{"lat":39.18566,"lon":-78.16333}},{"facility":"GSK Investigational Site","city":"Renton","state":"Washington","zip":"98057","country":"United States","geoPoint":{"lat":47.48288,"lon":-122.21707}},{"facility":"GSK Investigational Site","city":"Glebe","state":"New South Wales","zip":"2037","country":"Australia","geoPoint":{"lat":-33.87884,"lon":151.18426}},{"facility":"GSK Investigational Site","city":"Maroubra","state":"New South Wales","zip":"2035","country":"Australia","geoPoint":{"lat":-33.95,"lon":151.23333}},{"facility":"GSK Investigational Site","city":"Umina","state":"New South Wales","zip":"2257","country":"Australia"},{"facility":"GSK Investigational Site","city":"Westmead","state":"New South Wales","zip":"2145","country":"Australia","geoPoint":{"lat":-33.80383,"lon":150.98768}},{"facility":"GSK Investigational Site","city":"Wollongong","state":"New South Wales","zip":"2522","country":"Australia","geoPoint":{"lat":-34.424,"lon":150.89345}},{"facility":"GSK Investigational Site","city":"Sherwood","state":"Queensland","zip":"4075","country":"Australia","geoPoint":{"lat":-27.53034,"lon":152.98216}},{"facility":"GSK Investigational Site","city":"Geelong","state":"Victoria","zip":"3220","country":"Australia","geoPoint":{"lat":-38.14711,"lon":144.36069}},{"facility":"GSK Investigational Site","city":"Ivanhoe","state":"Victoria","zip":"3079","country":"Australia","geoPoint":{"lat":-37.76903,"lon":145.04308}},{"facility":"GSK Investigational Site","city":"Belo Horizonte","state":"Minas Gerais","zip":"30150-221","country":"Brazil","geoPoint":{"lat":-19.92083,"lon":-43.93778}},{"facility":"GSK Investigational Site","city":"Belo Horizonte","state":"Minas Gerais","zip":"30150-","country":"Brazil","geoPoint":{"lat":-19.92083,"lon":-43.93778}},{"facility":"GSK Investigational Site","city":"Curitiba/Paraná","state":"Paraná","zip":"80810-050","country":"Brazil"},{"facility":"GSK Investigational Site","city":"Curitiba/Paraná","state":"Paraná","zip":"80810-","country":"Brazil"},{"facility":"GSK Investigational Site","city":"Porto Alegre","state":"Rio Grande do Sul","zip":"90035003","country":"Brazil","geoPoint":{"lat":-30.03283,"lon":-51.23019}},{"facility":"GSK Investigational Site","city":"Porto Alegre","state":"Rio Grande do Sul","zip":"900350","country":"Brazil","geoPoint":{"lat":-30.03283,"lon":-51.23019}},{"facility":"GSK Investigational Site","city":"Curitiba/PR","zip":"80240-280","country":"Brazil"},{"facility":"GSK Investigational Site","city":"Curitiba/PR","zip":"80240-","country":"Brazil"},{"facility":"GSK Investigational Site","city":"São Paulo","zip":"04038 002","country":"Brazil","geoPoint":{"lat":-23.5475,"lon":-46.63611}},{"facility":"GSK Investigational Site","city":"São Paulo","zip":"04038","country":"Brazil","geoPoint":{"lat":-23.5475,"lon":-46.63611}},{"facility":"GSK Investigational Site","city":"São Paulo","zip":"04266-010","country":"Brazil","geoPoint":{"lat":-23.5475,"lon":-46.63611}},{"facility":"GSK Investigational Site","city":"São Paulo","zip":"04266-","country":"Brazil","geoPoint":{"lat":-23.5475,"lon":-46.63611}},{"facility":"GSK Investigational Site","city":"São Paulo","zip":"04312903","country":"Brazil","geoPoint":{"lat":-23.5475,"lon":-46.63611}},{"facility":"GSK Investigational Site","city":"São Paulo","zip":"043129","country":"Brazil","geoPoint":{"lat":-23.5475,"lon":-46.63611}},{"facility":"GSK Investigational Site","city":"Vancouver","state":"British Columbia","zip":"V5Z 1M9","country":"Canada","geoPoint":{"lat":49.24966,"lon":-123.11934}},{"facility":"GSK Investigational Site","city":"Vancouver","state":"British Columbia","zip":"V5Z 1M","country":"Canada","geoPoint":{"lat":49.24966,"lon":-123.11934}},{"facility":"GSK Investigational Site","city":"Victoria","state":"British Columbia","zip":"V8V 3P9","country":"Canada","geoPoint":{"lat":48.4359,"lon":-123.35155}},{"facility":"GSK Investigational Site","city":"Victoria","state":"British Columbia","zip":"V8V 3P","country":"Canada","geoPoint":{"lat":48.4359,"lon":-123.35155}},{"facility":"GSK Investigational Site","city":"Bay Roberts","state":"Newfoundland and Labrador","zip":"A0A 1G0","country":"Canada","geoPoint":{"lat":47.59989,"lon":-53.26478}},{"facility":"GSK Investigational Site","city":"Bay Roberts","state":"Newfoundland and Labrador","zip":"A0A 1G","country":"Canada","geoPoint":{"lat":47.59989,"lon":-53.26478}},{"facility":"GSK Investigational Site","city":"Halifax","state":"Nova Scotia","zip":"B3K 6R8","country":"Canada","geoPoint":{"lat":44.64269,"lon":-63.57688}},{"facility":"GSK Investigational Site","city":"Halifax","state":"Nova Scotia","zip":"B3K 6R","country":"Canada","geoPoint":{"lat":44.64269,"lon":-63.57688}},{"facility":"GSK Investigational Site","city":"Truro","state":"Nova Scotia","zip":"B2N 1L2","country":"Canada","geoPoint":{"lat":45.36685,"lon":-63.26538}},{"facility":"GSK Investigational Site","city":"Truro","state":"Nova Scotia","zip":"B2N 1L","country":"Canada","geoPoint":{"lat":45.36685,"lon":-63.26538}},{"facility":"GSK Investigational Site","city":"Toronto","state":"Ontario","zip":"M4S 1Y2","country":"Canada","geoPoint":{"lat":43.65333,"lon":-79.38389}},{"facility":"GSK Investigational Site","city":"Toronto","state":"Ontario","zip":"M4S 1Y","country":"Canada","geoPoint":{"lat":43.65333,"lon":-79.38389}},{"facility":"GSK Investigational Site","city":"Toronto","state":"Ontario","zip":"M9W 4L6","country":"Canada","geoPoint":{"lat":43.65333,"lon":-79.38389}},{"facility":"GSK Investigational Site","city":"Toronto","state":"Ontario","zip":"M9W 4L","country":"Canada","geoPoint":{"lat":43.65333,"lon":-79.38389}},{"facility":"GSK Investigational Site","city":"Woodstock","state":"Ontario","zip":"N4S 5P5","country":"Canada","geoPoint":{"lat":43.13339,"lon":-80.7497}},{"facility":"GSK Investigational Site","city":"Woodstock","state":"Ontario","zip":"N4S 5P","country":"Canada","geoPoint":{"lat":43.13339,"lon":-80.7497}},{"facility":"GSK Investigational Site","city":"Gatineau","state":"Quebec","zip":"J8Y 6S8","country":"Canada","geoPoint":{"lat":45.47723,"lon":-75.70164}},{"facility":"GSK Investigational Site","city":"Gatineau","state":"Quebec","zip":"J8Y 6S","country":"Canada","geoPoint":{"lat":45.47723,"lon":-75.70164}},{"facility":"GSK Investigational Site","city":"Mirabel","state":"Quebec","zip":"J7J 2K8","country":"Canada","geoPoint":{"lat":45.65008,"lon":-74.08251}},{"facility":"GSK Investigational Site","city":"Mirabel","state":"Quebec","zip":"J7J 2K","country":"Canada","geoPoint":{"lat":45.65008,"lon":-74.08251}},{"facility":"GSK Investigational Site","city":"Pointe-Claire","state":"Quebec","zip":"H9R 4S3","country":"Canada","geoPoint":{"lat":45.44868,"lon":-73.81669}},{"facility":"GSK Investigational Site","city":"Pointe-Claire","state":"Quebec","zip":"H9R 4S","country":"Canada","geoPoint":{"lat":45.44868,"lon":-73.81669}},{"facility":"GSK Investigational Site","city":"Québec","state":"Quebec","zip":"G1E 7G9","country":"Canada","geoPoint":{"lat":46.81228,"lon":-71.21454}},{"facility":"GSK Investigational Site","city":"Québec","state":"Quebec","zip":"G1E 7G","country":"Canada","geoPoint":{"lat":46.81228,"lon":-71.21454}},{"facility":"GSK Investigational Site","city":"Québec","state":"Quebec","zip":"G1W 4R4","country":"Canada","geoPoint":{"lat":46.81228,"lon":-71.21454}},{"facility":"GSK Investigational Site","city":"Québec","state":"Quebec","zip":"G1W 4R","country":"Canada","geoPoint":{"lat":46.81228,"lon":-71.21454}},{"facility":"GSK Investigational Site","city":"Sherbrooke","state":"Quebec","zip":"J1H 2G2","country":"Canada","geoPoint":{"lat":45.40008,"lon":-71.89908}},{"facility":"GSK Investigational Site","city":"Sherbrooke","state":"Quebec","zip":"J1H 2G","country":"Canada","geoPoint":{"lat":45.40008,"lon":-71.89908}},{"facility":"GSK Investigational Site","city":"Trois-Rivières","state":"Quebec","zip":"G8T 7A1","country":"Canada","geoPoint":{"lat":46.34515,"lon":-72.5477}},{"facility":"GSK Investigational Site","city":"Trois-Rivières","state":"Quebec","zip":"G8T 7A","country":"Canada","geoPoint":{"lat":46.34515,"lon":-72.5477}},{"facility":"GSK Investigational Site","city":"Brno","zip":"662 10","country":"Czechia","geoPoint":{"lat":49.19522,"lon":16.60796}},{"facility":"GSK Investigational Site","city":"České Budějovice","zip":"370 04","country":"Czechia","geoPoint":{"lat":48.97447,"lon":14.47434}},{"facility":"GSK Investigational Site","city":"Hradec Králové","zip":"500 01","country":"Czechia","geoPoint":{"lat":50.20923,"lon":15.83277}},{"facility":"GSK Investigational Site","city":"Tallinn","zip":"13619","country":"Estonia","geoPoint":{"lat":59.43696,"lon":24.75353}},{"facility":"GSK Investigational Site","city":"Tartu","zip":"50106","country":"Estonia","geoPoint":{"lat":58.38062,"lon":26.72509}},{"facility":"GSK Investigational Site","city":"Espoo","zip":"02230","country":"Finland","geoPoint":{"lat":60.2052,"lon":24.6522}},{"facility":"GSK Investigational Site","city":"Helsinki","zip":"00100","country":"Finland","geoPoint":{"lat":60.16952,"lon":24.93545}},{"facility":"GSK Investigational Site","city":"Helsinki","zip":"00930","country":"Finland","geoPoint":{"lat":60.16952,"lon":24.93545}},{"facility":"GSK Investigational Site","city":"Jarvenpaa","zip":"04400","country":"Finland","geoPoint":{"lat":60.47369,"lon":25.08992}},{"facility":"GSK Investigational Site","city":"Kokkola","zip":"67100","country":"Finland","geoPoint":{"lat":63.83847,"lon":23.13066}},{"facility":"GSK Investigational Site","city":"Oulu","zip":"90220","country":"Finland","geoPoint":{"lat":65.01236,"lon":25.46816}},{"facility":"GSK Investigational Site","city":"Pori","zip":"28100","country":"Finland","geoPoint":{"lat":61.48072,"lon":21.78518}},{"facility":"GSK Investigational Site","city":"Seinäjoki","zip":"60100","country":"Finland","geoPoint":{"lat":62.79446,"lon":22.82822}},{"facility":"GSK Investigational Site","city":"Tampere","zip":"33100","country":"Finland","geoPoint":{"lat":61.49911,"lon":23.78712}},{"facility":"GSK Investigational Site","city":"Turku","zip":"20520","country":"Finland","geoPoint":{"lat":60.45148,"lon":22.26869}},{"facility":"GSK Investigational Site","city":"Angers","zip":"49000","country":"France","geoPoint":{"lat":47.47156,"lon":-0.55202}},{"facility":"GSK Investigational Site","city":"Château-Gontier","zip":"53200","country":"France","geoPoint":{"lat":47.82705,"lon":-0.70512}},{"facility":"GSK Investigational Site","city":"Cherbourg","zip":"50100","country":"France","geoPoint":{"lat":49.63984,"lon":-1.61636}},{"facility":"GSK Investigational Site","city":"Clermont-Ferrand","zip":"63003","country":"France","geoPoint":{"lat":45.77969,"lon":3.08682}},{"facility":"GSK Investigational Site","city":"Laval","zip":"53000","country":"France","geoPoint":{"lat":48.07247,"lon":-0.77019}},{"facility":"GSK Investigational Site","city":"Laval","zip":"53100","country":"France","geoPoint":{"lat":48.07247,"lon":-0.77019}},{"facility":"GSK Investigational Site","city":"Montrevault","zip":"49110","country":"France","geoPoint":{"lat":47.26145,"lon":-1.04579}},{"facility":"GSK Investigational Site","city":"Muret","zip":"31600","country":"France","geoPoint":{"lat":43.45998,"lon":1.32541}},{"facility":"GSK Investigational Site","city":"Nantes","zip":"44300","country":"France","geoPoint":{"lat":47.21725,"lon":-1.55336}},{"facility":"GSK Investigational Site","city":"Rosiers-d'Égletons","zip":"19300","country":"France","geoPoint":{"lat":45.37738,"lon":2.00813}},{"facility":"GSK Investigational Site","city":"Saint Cyr Sur Loir","zip":"37540","country":"France"},{"facility":"GSK Investigational Site","city":"Segré","zip":"49500","country":"France","geoPoint":{"lat":47.68672,"lon":-0.87268}},{"facility":"GSK Investigational Site","city":"Soulaines-sur-Aubance","zip":"49610","country":"France","geoPoint":{"lat":47.3643,"lon":-0.5229}},{"facility":"GSK Investigational Site","city":"Tours","zip":"37100","country":"France","geoPoint":{"lat":47.39484,"lon":0.70398}},{"facility":"GSK Investigational Site","city":"Deggingen","state":"Baden-Wurttemberg","zip":"73326","country":"Germany","geoPoint":{"lat":48.5971,"lon":9.71891}},{"facility":"GSK Investigational Site","city":"Güglingen","state":"Baden-Wurttemberg","zip":"74363","country":"Germany","geoPoint":{"lat":49.06642,"lon":9.00175}},{"facility":"GSK Investigational Site","city":"Mannheim","state":"Baden-Wurttemberg","zip":"68161","country":"Germany","geoPoint":{"lat":49.4891,"lon":8.46694}},{"facility":"GSK Investigational Site","city":"Tübingen","state":"Baden-Wurttemberg","zip":"72074","country":"Germany","geoPoint":{"lat":48.52266,"lon":9.05222}},{"facility":"GSK Investigational Site","city":"Wangen","state":"Baden-Wurttemberg","zip":"88239","country":"Germany","geoPoint":{"lat":47.6895,"lon":9.83247}},{"facility":"GSK Investigational Site","city":"Weinheim","state":"Baden-Wurttemberg","zip":"69469","country":"Germany","geoPoint":{"lat":49.54887,"lon":8.66697}},{"facility":"GSK Investigational Site","city":"Dachau","state":"Bavaria","zip":"85221","country":"Germany","geoPoint":{"lat":48.26,"lon":11.43402}},{"facility":"GSK Investigational Site","city":"Künzing","state":"Bavaria","zip":"94550","country":"Germany","geoPoint":{"lat":48.66667,"lon":13.08333}},{"facility":"GSK Investigational Site","city":"Munich","state":"Bavaria","zip":"80339","country":"Germany","geoPoint":{"lat":48.13743,"lon":11.57549}},{"facility":"GSK Investigational Site","city":"Rednitzhembach","state":"Bavaria","zip":"91126","country":"Germany","geoPoint":{"lat":49.30095,"lon":11.07997}},{"facility":"GSK Investigational Site","city":"Wallerfing","state":"Bavaria","zip":"94574","country":"Germany","geoPoint":{"lat":48.68416,"lon":12.88035}},{"facility":"GSK Investigational Site","city":"Würzburg","state":"Bavaria","zip":"97070","country":"Germany","geoPoint":{"lat":49.79391,"lon":9.95121}},{"facility":"GSK Investigational Site","city":"Potsdam","state":"Brandenburg","zip":"14467","country":"Germany","geoPoint":{"lat":52.39886,"lon":13.06566}},{"facility":"GSK Investigational Site","city":"Flörsheim","state":"Hesse","zip":"65439","country":"Germany","geoPoint":{"lat":50.01311,"lon":8.42779}},{"facility":"GSK Investigational Site","city":"Frankfurt am Main","state":"Hesse","zip":"60389","country":"Germany","geoPoint":{"lat":50.11552,"lon":8.68417}},{"facility":"GSK Investigational Site","city":"Duelmen","state":"Lower Saxony","zip":"48249","country":"Germany"},{"facility":"GSK Investigational Site","city":"Cologne","state":"North Rhine-Westphalia","zip":"51069","country":"Germany","geoPoint":{"lat":50.93333,"lon":6.95}},{"facility":"GSK Investigational Site","city":"Essen","state":"North Rhine-Westphalia","zip":"45355","country":"Germany","geoPoint":{"lat":51.45657,"lon":7.01228}},{"facility":"GSK Investigational Site","city":"Essen","state":"North Rhine-Westphalia","zip":"45359","country":"Germany","geoPoint":{"lat":51.45657,"lon":7.01228}},{"facility":"GSK Investigational Site","city":"Goch","state":"North Rhine-Westphalia","zip":"47574","country":"Germany","geoPoint":{"lat":51.67873,"lon":6.15895}},{"facility":"GSK Investigational Site","city":"Witten","state":"North Rhine-Westphalia","zip":"58455","country":"Germany","geoPoint":{"lat":51.44362,"lon":7.35258}},{"facility":"GSK Investigational Site","city":"Mainz","state":"Rhineland-Palatinate","zip":"55116","country":"Germany","geoPoint":{"lat":49.98185,"lon":8.28008}},{"facility":"GSK Investigational Site","city":"Rhaunen","state":"Rhineland-Palatinate","zip":"55624","country":"Germany","geoPoint":{"lat":49.8638,"lon":7.34198}},{"facility":"GSK Investigational Site","city":"Dresden","state":"Saxony","zip":"01097","country":"Germany","geoPoint":{"lat":51.05089,"lon":13.73832}},{"facility":"GSK Investigational Site","city":"Freiberg","state":"Saxony","zip":"09599","country":"Germany","geoPoint":{"lat":50.91089,"lon":13.33881}},{"facility":"GSK Investigational Site","city":"Leipzig","state":"Saxony","zip":"04315","country":"Germany","geoPoint":{"lat":51.33962,"lon":12.37129}},{"facility":"GSK Investigational Site","city":"Pirna","state":"Saxony","zip":"01796","country":"Germany","geoPoint":{"lat":50.95843,"lon":13.93702}},{"facility":"GSK Investigational Site","city":"Köthen","state":"Saxony-Anhalt","zip":"06366","country":"Germany","geoPoint":{"lat":51.75185,"lon":11.97093}},{"facility":"GSK Investigational Site","city":"Magdeburg","state":"Saxony-Anhalt","zip":"39112","country":"Germany","geoPoint":{"lat":52.13129,"lon":11.63189}},{"facility":"GSK Investigational Site","city":"Lübeck","state":"Schleswig-Holstein","zip":"23554","country":"Germany","geoPoint":{"lat":53.86893,"lon":10.68729}},{"facility":"GSK Investigational Site","city":"Berlin","zip":"10629","country":"Germany","geoPoint":{"lat":52.52437,"lon":13.41053}},{"facility":"GSK Investigational Site","city":"Berlin","zip":"10717","country":"Germany","geoPoint":{"lat":52.52437,"lon":13.41053}},{"facility":"GSK Investigational Site","city":"Berlin","zip":"10787","country":"Germany","geoPoint":{"lat":52.52437,"lon":13.41053}},{"facility":"GSK Investigational Site","city":"Berlin","zip":"12157","country":"Germany","geoPoint":{"lat":52.52437,"lon":13.41053}},{"facility":"GSK Investigational Site","city":"Berlin","zip":"12351","country":"Germany","geoPoint":{"lat":52.52437,"lon":13.41053}},{"facility":"GSK Investigational Site","city":"Berlin","zip":"13347","country":"Germany","geoPoint":{"lat":52.52437,"lon":13.41053}},{"facility":"GSK Investigational Site","city":"Hamburg","zip":"20251","country":"Germany","geoPoint":{"lat":53.55073,"lon":9.99302}},{"facility":"GSK Investigational Site","city":"Hamburg","zip":"22143","country":"Germany","geoPoint":{"lat":53.55073,"lon":9.99302}},{"facility":"GSK Investigational Site","city":"Hamburg","zip":"22415","country":"Germany","geoPoint":{"lat":53.55073,"lon":9.99302}},{"facility":"GSK Investigational Site","city":"Kwun Tong","country":"Hong Kong","geoPoint":{"lat":22.31184,"lon":114.22176}},{"facility":"GSK Investigational Site","city":"Shatin","country":"Hong Kong","geoPoint":{"lat":22.38333,"lon":114.18333}},{"facility":"GSK Investigational Site","city":"Chieti","state":"Abruzzo","zip":"66013","country":"Italy","geoPoint":{"lat":42.34827,"lon":14.16494}},{"facility":"GSK Investigational Site","city":"Pescara","state":"Abruzzo","zip":"65100","country":"Italy","geoPoint":{"lat":42.4584,"lon":14.20283}},{"facility":"GSK Investigational Site","city":"Rome","state":"Lazio","zip":"00133","country":"Italy","geoPoint":{"lat":41.89193,"lon":12.51133}},{"facility":"GSK Investigational Site","city":"Rome","state":"Lazio","zip":"00163","country":"Italy","geoPoint":{"lat":41.89193,"lon":12.51133}},{"facility":"GSK Investigational Site","city":"Genoa","state":"Liguria","zip":"16132","country":"Italy","geoPoint":{"lat":44.40478,"lon":8.94439}},{"facility":"GSK Investigational Site","city":"Milan","state":"Lombardy","zip":"20122","country":"Italy","geoPoint":{"lat":45.46427,"lon":9.18951}},{"facility":"GSK Investigational Site","city":"Monza","state":"Lombardy","zip":"20052","country":"Italy","geoPoint":{"lat":45.58005,"lon":9.27246}},{"facility":"GSK Investigational Site","city":"Cuneo","state":"Piedmont","zip":"12100","country":"Italy","geoPoint":{"lat":44.39071,"lon":7.54828}},{"facility":"GSK Investigational Site","city":"Cagliari","state":"Sardinia","zip":"09127","country":"Italy","geoPoint":{"lat":39.23054,"lon":9.11917}},{"facility":"GSK Investigational Site","city":"Sassari","state":"Sardinia","zip":"07100","country":"Italy","geoPoint":{"lat":40.72586,"lon":8.55552}},{"facility":"GSK Investigational Site","city":"Catania","state":"Sicily","zip":"95129","country":"Italy","geoPoint":{"lat":37.49223,"lon":15.07041}},{"facility":"GSK Investigational Site","city":"Ragusa (RG)","state":"Sicily","zip":"97100","country":"Italy","geoPoint":{"lat":36.92574,"lon":14.72443}},{"facility":"GSK Investigational Site","city":"Fukuoka","zip":"810-0021","country":"Japan","geoPoint":{"lat":33.6,"lon":130.41667}},{"facility":"GSK Investigational Site","city":"Fukuoka","zip":"810-00","country":"Japan","geoPoint":{"lat":33.6,"lon":130.41667}},{"facility":"GSK Investigational Site","city":"Fukuoka","zip":"812-0025","country":"Japan","geoPoint":{"lat":33.6,"lon":130.41667}},{"facility":"GSK Investigational Site","city":"Fukuoka","zip":"812-00","country":"Japan","geoPoint":{"lat":33.6,"lon":130.41667}},{"facility":"GSK Investigational Site","city":"Fukuoka","zip":"813-8588","country":"Japan","geoPoint":{"lat":33.6,"lon":130.41667}},{"facility":"GSK Investigational Site","city":"Fukuoka","zip":"813-85","country":"Japan","geoPoint":{"lat":33.6,"lon":130.41667}},{"facility":"GSK Investigational Site","city":"Fukuoka","zip":"816-0864","country":"Japan","geoPoint":{"lat":33.6,"lon":130.41667}},{"facility":"GSK Investigational Site","city":"Fukuoka","zip":"816-08","country":"Japan","geoPoint":{"lat":33.6,"lon":130.41667}},{"facility":"GSK Investigational Site","city":"Kanagawa","zip":"224-8503","country":"Japan","geoPoint":{"lat":37.58333,"lon":139.91667}},{"facility":"GSK Investigational Site","city":"Kanagawa","zip":"224-85","country":"Japan","geoPoint":{"lat":37.58333,"lon":139.91667}},{"facility":"GSK Investigational Site","city":"Kanagawa","zip":"247-8533","country":"Japan","geoPoint":{"lat":37.58333,"lon":139.91667}},{"facility":"GSK Investigational Site","city":"Kanagawa","zip":"247-85","country":"Japan","geoPoint":{"lat":37.58333,"lon":139.91667}},{"facility":"GSK Investigational Site","city":"Kyoto","zip":"611-0041","country":"Japan","geoPoint":{"lat":35.02107,"lon":135.75385}},{"facility":"GSK Investigational Site","city":"Kyoto","zip":"611-00","country":"Japan","geoPoint":{"lat":35.02107,"lon":135.75385}},{"facility":"GSK Investigational Site","city":"Tokyo","zip":"141-0001","country":"Japan","geoPoint":{"lat":35.6895,"lon":139.69171}},{"facility":"GSK Investigational Site","city":"Tokyo","zip":"141-00","country":"Japan","geoPoint":{"lat":35.6895,"lon":139.69171}},{"facility":"GSK Investigational Site","city":"Tokyo","zip":"142-8666","country":"Japan","geoPoint":{"lat":35.6895,"lon":139.69171}},{"facility":"GSK Investigational Site","city":"Tokyo","zip":"142-86","country":"Japan","geoPoint":{"lat":35.6895,"lon":139.69171}},{"facility":"GSK Investigational Site","city":"Tokyo","zip":"154-0024","country":"Japan","geoPoint":{"lat":35.6895,"lon":139.69171}},{"facility":"GSK Investigational Site","city":"Tokyo","zip":"154-00","country":"Japan","geoPoint":{"lat":35.6895,"lon":139.69171}},{"facility":"GSK Investigational Site","city":"Zapopan, Jalisco","state":"Jalisco","zip":"45190","country":"Mexico"},{"facility":"GSK Investigational Site","city":"Cuernavaca","state":"Morelos","zip":"62210","country":"Mexico","geoPoint":{"lat":18.9261,"lon":-99.23075}},{"facility":"GSK Investigational Site","city":"Durango","zip":"34000","country":"Mexico","geoPoint":{"lat":24.02032,"lon":-104.65756}},{"facility":"GSK Investigational Site","city":"Monterrey","country":"Mexico","geoPoint":{"lat":25.68435,"lon":-100.31721}},{"facility":"GSK Investigational Site","city":"Ansan","zip":"425-707","country":"South Korea","geoPoint":{"lat":37.365,"lon":127.46389}},{"facility":"GSK Investigational Site","city":"Ansan","zip":"425-70","country":"South Korea","geoPoint":{"lat":37.365,"lon":127.46389}},{"facility":"GSK Investigational Site","city":"Bucheon-si","zip":"420-767","country":"South Korea","geoPoint":{"lat":37.49889,"lon":126.78306}},{"facility":"GSK Investigational Site","city":"Bucheon-si","zip":"420-76","country":"South Korea","geoPoint":{"lat":37.49889,"lon":126.78306}},{"facility":"GSK Investigational Site","city":"Incheon","zip":"400-711","country":"South Korea","geoPoint":{"lat":37.45646,"lon":126.70515}},{"facility":"GSK Investigational Site","city":"Incheon","zip":"400-71","country":"South Korea","geoPoint":{"lat":37.45646,"lon":126.70515}},{"facility":"GSK Investigational Site","city":"Kangnam-gu, Seoul","country":"South Korea","geoPoint":{"lat":37.566,"lon":126.9784}},{"facility":"GSK Investigational Site","city":"Kangwon-do","zip":"220-701","country":"South Korea"},{"facility":"GSK Investigational Site","city":"Kangwon-do","zip":"220-70","country":"South Korea"},{"facility":"GSK Investigational Site","city":"Seoul","zip":"135-710","country":"South Korea","geoPoint":{"lat":37.566,"lon":126.9784}},{"facility":"GSK Investigational Site","city":"Seoul","zip":"135-71","country":"South Korea","geoPoint":{"lat":37.566,"lon":126.9784}},{"facility":"GSK Investigational Site","city":"Seoul","zip":"150-950","country":"South Korea","geoPoint":{"lat":37.566,"lon":126.9784}},{"facility":"GSK Investigational Site","city":"Seoul","zip":"150-95","country":"South Korea","geoPoint":{"lat":37.566,"lon":126.9784}},{"facility":"GSK Investigational Site","city":"Seoul","zip":"152-703","country":"South Korea","geoPoint":{"lat":37.566,"lon":126.9784}},{"facility":"GSK Investigational Site","city":"Seoul","zip":"152-70","country":"South Korea","geoPoint":{"lat":37.566,"lon":126.9784}},{"facility":"GSK Investigational Site","city":"Alcover( Tarragona)","zip":"43460","country":"Spain","geoPoint":{"lat":41.26267,"lon":1.1701}},{"facility":"GSK Investigational Site","city":"Balenyà (Barcelona)","zip":"08550","country":"Spain"},{"facility":"GSK Investigational Site","city":"Barcelona","zip":"08025","country":"Spain","geoPoint":{"lat":41.38879,"lon":2.15899}},{"facility":"GSK Investigational Site","city":"Barcelona","zip":"08035","country":"Spain","geoPoint":{"lat":41.38879,"lon":2.15899}},{"facility":"GSK Investigational Site","city":"Centelles","country":"Spain","geoPoint":{"lat":41.79746,"lon":2.21902}},{"facility":"GSK Investigational Site","city":"La Roca Del Valles (Barcelona)","zip":"08430","country":"Spain","geoPoint":{"lat":41.58333,"lon":2.33333}},{"facility":"GSK Investigational Site","city":"Madrid","zip":"28040","country":"Spain","geoPoint":{"lat":40.4165,"lon":-3.70256}},{"facility":"GSK Investigational Site","city":"Madrid","zip":"28046","country":"Spain","geoPoint":{"lat":40.4165,"lon":-3.70256}},{"facility":"GSK Investigational Site","city":"Majadahonda","country":"Spain","geoPoint":{"lat":40.47353,"lon":-3.87182}},{"facility":"GSK Investigational Site","city":"Peralada( Girona)","zip":"17491","country":"Spain","geoPoint":{"lat":42.30823,"lon":3.0091}},{"facility":"GSK Investigational Site","city":"Valencia","zip":"46020","country":"Spain","geoPoint":{"lat":39.47391,"lon":-0.37966}},{"facility":"GSK Investigational Site","city":"Vic/ Barcelona","zip":"08500","country":"Spain"},{"facility":"GSK Investigational Site","city":"Borås","zip":"SE-506 30","country":"Sweden","geoPoint":{"lat":57.72101,"lon":12.9401}},{"facility":"GSK Investigational Site","city":"Borås","zip":"SE-506","country":"Sweden","geoPoint":{"lat":57.72101,"lon":12.9401}},{"facility":"GSK Investigational Site","city":"Eskilstuna","zip":"SE-631 88","country":"Sweden","geoPoint":{"lat":59.36661,"lon":16.5077}},{"facility":"GSK Investigational Site","city":"Eskilstuna","zip":"SE-631","country":"Sweden","geoPoint":{"lat":59.36661,"lon":16.5077}},{"facility":"GSK Investigational Site","city":"Gothenburg","zip":"SE-413 45","country":"Sweden","geoPoint":{"lat":57.70716,"lon":11.96679}},{"facility":"GSK Investigational Site","city":"Gothenburg","zip":"SE-413","country":"Sweden","geoPoint":{"lat":57.70716,"lon":11.96679}},{"facility":"GSK Investigational Site","city":"Jönköping","zip":"SE-551 85","country":"Sweden","geoPoint":{"lat":57.78145,"lon":14.15618}},{"facility":"GSK Investigational Site","city":"Jönköping","zip":"SE-551","country":"Sweden","geoPoint":{"lat":57.78145,"lon":14.15618}},{"facility":"GSK Investigational Site","city":"Karlskrona","zip":"SE-371 41","country":"Sweden","geoPoint":{"lat":56.16156,"lon":15.58661}},{"facility":"GSK Investigational Site","city":"Karlskrona","zip":"SE-371","country":"Sweden","geoPoint":{"lat":56.16156,"lon":15.58661}},{"facility":"GSK Investigational Site","city":"Linköping","zip":"SE-58758","country":"Sweden","geoPoint":{"lat":58.41086,"lon":15.62157}},{"facility":"GSK Investigational Site","city":"Linköping","zip":"SE-587","country":"Sweden","geoPoint":{"lat":58.41086,"lon":15.62157}},{"facility":"GSK Investigational Site","city":"Malmö","zip":"SE-211 52","country":"Sweden","geoPoint":{"lat":55.60587,"lon":13.00073}},{"facility":"GSK Investigational Site","city":"Malmö","zip":"SE-211","country":"Sweden","geoPoint":{"lat":55.60587,"lon":13.00073}},{"facility":"GSK Investigational Site","city":"Örebro","zip":"SE-703 62","country":"Sweden","geoPoint":{"lat":59.27412,"lon":15.2066}},{"facility":"GSK Investigational Site","city":"Örebro","zip":"SE-703","country":"Sweden","geoPoint":{"lat":59.27412,"lon":15.2066}},{"facility":"GSK Investigational Site","city":"Skövde","zip":"SE-541 85","country":"Sweden","geoPoint":{"lat":58.39118,"lon":13.84506}},{"facility":"GSK Investigational Site","city":"Skövde","zip":"SE-541","country":"Sweden","geoPoint":{"lat":58.39118,"lon":13.84506}},{"facility":"GSK Investigational Site","city":"Stockholm","zip":"SE-111 57","country":"Sweden","geoPoint":{"lat":59.32938,"lon":18.06871}},{"facility":"GSK Investigational Site","city":"Stockholm","zip":"SE-111","country":"Sweden","geoPoint":{"lat":59.32938,"lon":18.06871}},{"facility":"GSK Investigational Site","city":"Uppsala","zip":"SE-751 85","country":"Sweden","geoPoint":{"lat":59.85882,"lon":17.63889}},{"facility":"GSK Investigational Site","city":"Uppsala","zip":"SE-751","country":"Sweden","geoPoint":{"lat":59.85882,"lon":17.63889}},{"facility":"GSK Investigational Site","city":"Vällingby","zip":"SE-162 68","country":"Sweden","geoPoint":{"lat":59.36441,"lon":17.87407}},{"facility":"GSK Investigational Site","city":"Vällingby","zip":"SE-162","country":"Sweden","geoPoint":{"lat":59.36441,"lon":17.87407}},{"facility":"GSK Investigational Site","city":"Taichung","zip":"40447","country":"Taiwan","geoPoint":{"lat":24.1469,"lon":120.6839}},{"facility":"GSK Investigational Site","city":"Taipei","zip":"112","country":"Taiwan","geoPoint":{"lat":25.05306,"lon":121.52639}},{"facility":"GSK Investigational Site","city":"Taipei","country":"Taiwan","geoPoint":{"lat":25.05306,"lon":121.52639}},{"facility":"GSK Investigational Site","city":"Taoyuan","zip":"333","country":"Taiwan","geoPoint":{"lat":24.99368,"lon":121.29696}},{"facility":"GSK Investigational Site","city":"Buckshaw Village, Chorley","state":"Lancashire","zip":"PR7 7NA","country":"United Kingdom","geoPoint":{"lat":53.65,"lon":-2.61667}},{"facility":"GSK Investigational Site","city":"Buckshaw Village, Chorley","state":"Lancashire","zip":"PR7 7N","country":"United Kingdom","geoPoint":{"lat":53.65,"lon":-2.61667}},{"facility":"GSK Investigational Site","city":"Atherstone","state":"Warwickshire","zip":"CV9 1EU","country":"United Kingdom","geoPoint":{"lat":52.57536,"lon":-1.54693}},{"facility":"GSK Investigational Site","city":"Atherstone","state":"Warwickshire","zip":"CV9 1E","country":"United Kingdom","geoPoint":{"lat":52.57536,"lon":-1.54693}},{"facility":"GSK Investigational Site","city":"Bradford on Avon","state":"Wiltshire","zip":"BA15 1DQ","country":"United Kingdom","geoPoint":{"lat":51.34772,"lon":-2.25065}},{"facility":"GSK Investigational Site","city":"Bradford on Avon","state":"Wiltshire","zip":"BA15 1","country":"United Kingdom","geoPoint":{"lat":51.34772,"lon":-2.25065}},{"facility":"GSK Investigational Site","city":"Bangor","zip":"BT19 1PP","country":"United Kingdom","geoPoint":{"lat":54.66079,"lon":-5.66802}},{"facility":"GSK Investigational Site","city":"Bangor","zip":"BT19 1","country":"United Kingdom","geoPoint":{"lat":54.66079,"lon":-5.66802}},{"facility":"GSK Investigational Site","city":"Belfast","zip":"BT7 2EB","country":"United Kingdom","geoPoint":{"lat":54.59682,"lon":-5.92541}},{"facility":"GSK Investigational Site","city":"Belfast","zip":"BT7 2E","country":"United Kingdom","geoPoint":{"lat":54.59682,"lon":-5.92541}},{"facility":"GSK Investigational Site","city":"Broughshane","zip":"BT42 4JP","country":"United Kingdom","geoPoint":{"lat":54.8926,"lon":-6.20899}},{"facility":"GSK Investigational Site","city":"Broughshane","zip":"BT42 4","country":"United Kingdom","geoPoint":{"lat":54.8926,"lon":-6.20899}},{"facility":"GSK Investigational Site","city":"Ledbury","zip":"HR8 2AA","country":"United Kingdom","geoPoint":{"lat":52.03639,"lon":-2.42635}},{"facility":"GSK Investigational Site","city":"Ledbury","zip":"HR8 2A","country":"United Kingdom","geoPoint":{"lat":52.03639,"lon":-2.42635}},{"facility":"GSK Investigational Site","city":"Newtonabbey","zip":"BT37 9QW","country":"United Kingdom"},{"facility":"GSK Investigational Site","city":"Newtonabbey","zip":"BT37 9","country":"United Kingdom"},{"facility":"GSK Investigational Site","city":"Waterloo, Liverpool","zip":"L22 0LG","country":"United Kingdom"},{"facility":"GSK Investigational Site","city":"Waterloo, Liverpool","zip":"L22 0L","country":"United Kingdom"}]},"referencesModule":{"references":[{"pmid":"27626517","type":"BACKGROUND","citation":"Cunningham AL, Lal H, Kovac M, Chlibek R, Hwang SJ, Diez-Domingo J, Godeaux O, Levin MJ, McElhaney JE, Puig-Barbera J, Vanden Abeele C, Vesikari T, Watanabe D, Zahaf T, Ahonen A, Athan E, Barba-Gomez JF, Campora L, de Looze F, Downey HJ, Ghesquiere W, Gorfinkel I, Korhonen T, Leung E, McNeil SA, Oostvogels L, Rombo L, Smetana J, Weckx L, Yeo W, Heineman TC; ZOE-70 Study Group. Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older. N Engl J Med. 2016 Sep 15;375(11):1019-32. doi: 10.1056/NEJMoa1603800."},{"pmid":"29529222","type":"BACKGROUND","citation":"Cunningham AL, Heineman TC, Lal H, Godeaux O, Chlibek R, Hwang SJ, McElhaney JE, Vesikari T, Andrews C, Choi WS, Esen M, Ikematsu H, Choma MK, Pauksens K, Ravault S, Salaun B, Schwarz TF, Smetana J, Abeele CV, Van den Steen P, Vastiau I, Weckx LY, Levin MJ; ZOE-50/70 Study Group. Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older. J Infect Dis. 2018 May 5;217(11):1750-1760. doi: 10.1093/infdis/jiy095."},{"type":"BACKGROUND","citation":"Ikematsu H et al. (2018) Efficacy, safety and immunogenicity of new adjuvanted herpes zoster subunit vaccine for Japanese over 50 years old and over 70 years old. Kansenshogaku Zasshi. 92(2):103-114."},{"pmid":"29463421","type":"BACKGROUND","citation":"Kovac M, Lal H, Cunningham AL, Levin MJ, Johnson RW, Campora L, Volpi A, Heineman TC; ZOE-50/70 Study Group. Complications of herpes zoster in immunocompetent older adults: Incidence in vaccine and placebo groups in two large phase 3 trials. Vaccine. 2018 Mar 14;36(12):1537-1541. doi: 10.1016/j.vaccine.2018.02.029. Epub 2018 Feb 17."},{"pmid":"25916341","type":"BACKGROUND","citation":"Lal H, Cunningham AL, Godeaux O, Chlibek R, Diez-Domingo J, Hwang SJ, Levin MJ, McElhaney JE, Poder A, Puig-Barbera J, Vesikari T, Watanabe D, Weckx L, Zahaf T, Heineman TC; ZOE-50 Study Group. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med. 2015 May 28;372(22):2087-96. doi: 10.1056/NEJMoa1501184. Epub 2015 Apr 28."},{"pmid":"37166199","type":"DERIVED","citation":"Matthews S, Curran D, Sabater Cabrera E, Boutry C, Lecrenier N, Cunningham AL, Schmader K. An Analysis of How Herpes Zoster Pain Affects Health-related Quality of Life of Placebo Patients From 3 Randomized Phase III Studies. Clin J Pain. 2023 Aug 1;39(8):386-393. doi: 10.1097/AJP.0000000000001129."},{"pmid":"36066965","type":"DERIVED","citation":"Kim JH, Johnson R, Kovac M, Cunningham AL, Amakrane M, Sullivan KM, Dagnew AF, Curran D, Schuind A. Adjuvanted recombinant zoster vaccine decreases herpes zoster-associated pain and the use of pain medication across 3 randomized, placebo-controlled trials. Pain. 2023 Apr 1;164(4):741-748. doi: 10.1097/j.pain.0000000000002760. Epub 2022 Aug 19."},{"pmid":"34609490","type":"DERIVED","citation":"Carryn S, Cheuvart B, Povey M, Dagnew AF, Harpaz R, van der Most R, Casabona G. No Consistent Evidence of Decreased Exposure to Varicella-Zoster Virus Among Older Adults in Countries with Universal Varicella Vaccination. J Infect Dis. 2022 Feb 1;225(3):413-421. doi: 10.1093/infdis/jiab500."},{"pmid":"33606577","type":"DERIVED","citation":"Kim JH, Diaz-Decaro J, Jiang N, Hwang SJ, Choo EJ, Co M, Hastie A, Hui DSC, Irimajiri J, Lee J, Leung EM, Tang H, Tsuru T, Watson P, Wu Z, Yu CJ, Yuan Y, Zahaf T, Cunningham AL, Schuind A. The adjuvanted recombinant zoster vaccine is efficacious and safe in Asian adults >/= 50 years of age: a sub-cohort analysis of the ZOE-50 and ZOE-70 randomized trials. Hum Vaccin Immunother. 2021 Jul 3;17(7):2050-2057. doi: 10.1080/21645515.2020.1859321. Epub 2021 Feb 19."},{"pmid":"32910152","type":"DERIVED","citation":"Dagnew AF, Rausch D, Herve C, Zahaf T, Levin MJ, Schuind A; ZOE-50/70 study group. Efficacy and serious adverse events profile of the adjuvanted recombinant zoster vaccine in adults with pre-existing potential immune-mediated diseases: a pooled post hoc analysis on two parallel randomized trials. Rheumatology (Oxford). 2021 Mar 2;60(3):1226-1233. doi: 10.1093/rheumatology/keaa424."},{"pmid":"32347767","type":"DERIVED","citation":"Colindres R, Wascotte V, Brecx A, Clarke C, Herve C, Kim JH, Levin MJ, Oostvogels L, Zahaf T, Schuind A, Cunningham AL. Post hoc analysis of reactogenicity trends between dose 1 and dose 2 of the adjuvanted recombinant zoster vaccine in two parallel randomized trials. Hum Vaccin Immunother. 2020 Nov 1;16(11):2628-2633. doi: 10.1080/21645515.2020.1741312. Epub 2020 Apr 29."},{"pmid":"31537443","type":"DERIVED","citation":"Willer DO, Oostvogels L, Cunningham AL, Gervais P, Gorfinkel I, Hyung Kim J, Talarico C, Wascotte V, Zahaf T, Colindres R, Schuind A; ZOE 50/70 study groups. Efficacy of the adjuvanted recombinant zoster vaccine (RZV) by sex, geographic region, and geographic ancestry/ethnicity: A post-hoc analysis of the ZOE-50 and ZOE-70 randomized trials. Vaccine. 2019 Oct 8;37(43):6262-6267. doi: 10.1016/j.vaccine.2019.09.028. Epub 2019 Sep 16."},{"pmid":"30935742","type":"DERIVED","citation":"Lopez-Fauqued M, Campora L, Delannois F, El Idrissi M, Oostvogels L, De Looze FJ, Diez-Domingo J, Heineman TC, Lal H, McElhaney JE, McNeil SA, Yeo W, Tavares-Da-Silva F; ZOE-50/70 Study Group. Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials. Vaccine. 2019 Apr 24;37(18):2482-2493. doi: 10.1016/j.vaccine.2019.03.043. Epub 2019 Mar 29."},{"pmid":"29955836","type":"DERIVED","citation":"Curran D, Oostvogels L, Heineman T, Matthews S, McElhaney J, McNeil S, Diez-Domingo J, Lal H, Andrews C, Athan E, Berglund J, Campora L, de Looze F, Korhonen T, Leung E, Levin M, Volpi A, Johnson RW; ZOE-50/70 Study Group. Quality of Life Impact of an Adjuvanted Recombinant Zoster Vaccine in Adults Aged 50 Years and Older. J Gerontol A Biol Sci Med Sci. 2019 Jul 12;74(8):1231-1238. doi: 10.1093/gerona/gly150."}],"seeAlsoLinks":[{"label":"IPD for this study will be made available via the Clinical Study Data Request site.","url":"https://clinicalstudydatarequest.com"}]},"ipdSharingStatementModule":{"ipdSharing":"YES","description":"IPD for this study will be made available via the Clinical Study Data Request site.","infoTypes":["STUDY_PROTOCOL","SAP","ICF","CSR"],"timeFrame":"IPD is available via the Clinical Study Data Request site (click on the link provided below)","accessCriteria":"Access is provided after a research proposal is submitted and has received approval from the Independent Review Panel and after a Data Sharing Agreement is in place. Access is provided for an initial period of 12 months but an extension can be granted, when justified, for up to another 12 months.","url":"https://clinicalstudydatarequest.com"}},"resultsSection":{"participantFlowModule":{"preAssignmentDetails":"Out of all the subjects enrolled into this study, only 15405 received vaccination and were hence considered to start the study.","groups":[{"id":"FG000","title":"GSK1437173A Group","description":"Subjects received herpes zoster subunit vaccine (gE/AS01B vaccine: GSK1437173A) according to a 0, 2-month schedule."},{"id":"FG001","title":"Placebo Group","description":"Subjects received saline solution (NaCl solution) as control according to a 0, 2-month schedule."}],"periods":[{"title":"Overall Study","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"7695"},{"groupId":"FG001","numSubjects":"7710"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"6773"},{"groupId":"FG001","numSubjects":"6808"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"922"},{"groupId":"FG001","numSubjects":"902"}]}],"dropWithdraws":[{"type":"Serious Adverse Event","reasons":[{"groupId":"FG000","numSubjects":"227"},{"groupId":"FG001","numSubjects":"235"}]},{"type":"Withdrawal by Subject","reasons":[{"groupId":"FG000","numSubjects":"368"},{"groupId":"FG001","numSubjects":"354"}]},{"type":"Protocol Violation","reasons":[{"groupId":"FG000","numSubjects":"19"},{"groupId":"FG001","numSubjects":"21"}]},{"type":"Non-serious adverse event","reasons":[{"groupId":"FG000","numSubjects":"30"},{"groupId":"FG001","numSubjects":"18"}]},{"type":"Other unspecified reasons","reasons":[{"groupId":"FG000","numSubjects":"47"},{"groupId":"FG001","numSubjects":"35"}]},{"type":"Suspected HZ episode","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"2"}]},{"type":"Lost to Follow-up","reasons":[{"groupId":"FG000","numSubjects":"183"},{"groupId":"FG001","numSubjects":"194"}]},{"type":"Migrated/ moved from study area","reasons":[{"groupId":"FG000","numSubjects":"48"},{"groupId":"FG001","numSubjects":"43"}]}]}]},"baselineCharacteristicsModule":{"groups":[{"id":"BG000","title":"GSK1437173A Group","description":"Subjects received herpes zoster subunit vaccine (gE/AS01B vaccine: GSK1437173A) according to a 0, 2-month schedule."},{"id":"BG001","title":"Placebo Group","description":"Subjects received saline solution (NaCl solution) as control according to a 0, 2-month schedule."},{"id":"BG002","title":"Total","description":"Total of all reporting groups"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"7695"},{"groupId":"BG001","value":"7710"},{"groupId":"BG002","value":"15405"}]}],"measures":[{"title":"Age, Continuous","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"Years","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"62.4","spread":"9.0"},{"groupId":"BG001","value":"62.3","spread":"9.0"},{"groupId":"BG002","value":"62.35","spread":"9.0"}]}]}]},{"title":"Age, Customized","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"title":"50 - 59 YOA","categories":[{"measurements":[{"groupId":"BG000","value":"3644"},{"groupId":"BG001","value":"3642"},{"groupId":"BG002","value":"7286"}]}]},{"title":"60 - 69 YOA","categories":[{"measurements":[{"groupId":"BG000","value":"2243"},{"groupId":"BG001","value":"2245"},{"groupId":"BG002","value":"4488"}]}]},{"title":">= 70 YOA","categories":[{"measurements":[{"groupId":"BG000","value":"1808"},{"groupId":"BG001","value":"1823"},{"groupId":"BG002","value":"3631"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"4709"},{"groupId":"BG001","value":"4711"},{"groupId":"BG002","value":"9420"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"2986"},{"groupId":"BG001","value":"2999"},{"groupId":"BG002","value":"5985"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Subjects With Confirmed Herpes Zoster (HZ) Cases","description":"Confirmed HZ cases during the study were assessed in the Modified Total Vaccinated Cohort (mTVc)","populationDescription":"The analysis was based on the modified total vaccinated cohort, which included subjects from the total vaccinated cohort, except those who were not administered with the second vaccination or who developed a confirmed case of Herpes Zoster prior to 1 month after the second vaccination.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"During the entire study period (3 to 5 year period following Day 0)","groups":[{"id":"OG000","title":"GSK1437173A 50-59 YOA Group","description":"Subjects aged between 50 and 59 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG001","title":"GSK1437173A 60-69 YOA Group","description":"Subjects aged between 60 and 69 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG002","title":"GSK1437173A Over 70 YOA Group","description":"Subjects aged above 70 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG003","title":"GSK1437173A Overall Ages Group","description":"Subjects aged over 50 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG004","title":"Placebo 50-59 YOA Group","description":"Subjects aged between 50 and 59 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG005","title":"Placebo 60-69 YOA Group","description":"Subjects aged between 60 and 69 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG006","title":"Placebo Over 70 YOA Group","description":"Subjects aged above 70 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG007","title":"Placebo Overall Ages Group","description":"Subjects aged over 50 years of age (YOA), receiving placebo according to a 0, 2-month schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"3492"},{"groupId":"OG001","value":"2141"},{"groupId":"OG002","value":"1711"},{"groupId":"OG003","value":"7344"},{"groupId":"OG004","value":"3525"},{"groupId":"OG005","value":"2166"},{"groupId":"OG006","value":"1724"},{"groupId":"OG007","value":"7415"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"6"},{"groupId":"OG004","value":"87"},{"groupId":"OG005","value":"75"},{"groupId":"OG006","value":"48"},{"groupId":"OG007","value":"210"}]}]}],"analyses":[{"groupIds":["OG000","OG004"],"groupDescription":"Comparison of vaccine efficacy in prevention of HZ between GSK1437173A 50-59 YOA group and placebo 50-59 YOA group","nonInferiorityType":"OTHER","nonInferiorityComment":"Criteria for the vaccine efficacy (VE) objective of herpes zoster subunit (HZ/su) vaccine against herpes zoster (HZ) disease, in the 50-59 YOA strata : The lower limit (LL) of the two-sided 95% confidence interval (CI) of VE had to be above 10%.","pValue":"<0.0001","pValueComment":"Two sided exact P-value conditional to number of cases.","statisticalMethod":"Poisson exact test","paramType":"Vaccine efficacy","paramValue":"96.6","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"89.6","ciUpperLimit":"99.3"},{"groupIds":["OG001","OG005"],"groupDescription":"Comparison of vaccine efficacy in prevention of HZ between GSK1437173A over 60-69 YOA group and placebo over 60-69 YOA group","nonInferiorityType":"OTHER","nonInferiorityComment":"Criteria for the VE objective of HZ/su vaccine against herpes zoster disease, in the 60-69 YOA strata : The lower limit (LL) of the two-sided 95% confidence interval (CI) of VE had to be above 10%.","pValue":"<0.0001","pValueComment":"Two sided exact P-value conditional to number of cases.","statisticalMethod":"Poisson exact test","paramType":"Vaccine efficacy","paramValue":"97.4","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"90.1","ciUpperLimit":"99.7"},{"groupIds":["OG002","OG006"],"groupDescription":"Comparison of vaccine efficacy in prevention of HZ between GSK1437173A over 70 YOA group and placebo over 70 YOA group","nonInferiorityType":"OTHER","nonInferiorityComment":"Criteria for the VE objective of HZ/su vaccine against herpes zoster disease, in the 70-79 YOA strata : The lower limit (LL) of the two-sided 95% confidence interval (CI) of VE had to be above 10%.","pValue":"0.0001","pValueComment":"Two sided exact P-value conditional to number of cases.","statisticalMethod":"Poisson exact test","paramType":"Vaccine efficacy","paramValue":"97.9","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"87.9","ciUpperLimit":"100"},{"groupIds":["OG003","OG007"],"groupDescription":"Comparison of vaccine efficacy in prevention of HZ between GSK1437173A overall ages group and placebo overall ages group","nonInferiorityType":"OTHER","nonInferiorityComment":"Criteria for the VE objective of HZ/su vaccine against herpes zoster disease, in the overall age strata : The lower limit (LL) of the two-sided 95% confidence interval (CI) of VE had to be above 10%.","pValue":"<0.0001","pValueComment":"Two sided exact P-value conditional to number of cases.","statisticalMethod":"Poisson exact test","paramType":"Vaccine efficacy","paramValue":"97.2","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"93.7","ciUpperLimit":"99"}]},{"type":"SECONDARY","title":"Number of Subjects With Any Episodes of Post-Herpetic Neuralgia (PHN)","description":"The incidence of PHN was calculated using the modified total vaccinated chort.","populationDescription":"The analysis was based on the modified total vaccinated cohort, which included subjects from the total vaccinated cohort, except those who were not administered with the second vaccination or who developed a confirmed case of Herpes Zoster prior to 1 month after the second vaccination.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"During the entire study period (3 to 5 year period following Day 0)","groups":[{"id":"OG000","title":"GSK1437173A 50-59 YOA Group","description":"Subjects aged between 50 and 59 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG001","title":"GSK1437173A 60-69 YOA Group","description":"Subjects aged between 60 and 69 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG002","title":"GSK1437173A Over 70 YOA Group","description":"Subjects aged above 70 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG003","title":"GSK1437173A Overall Ages Group","description":"Subjects aged over 50 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG004","title":"Placebo 50-59 YOA Group","description":"Subjects aged between 50 and 59 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG005","title":"Placebo 60-69 YOA Group","description":"Subjects aged between 60 and 69 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG006","title":"Placebo Over 70 YOA Group","description":"Subjects aged above 70 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG007","title":"Placebo Overall Ages Group","description":"Subjects aged over 50 years of age (YOA), receiving placebo according to a 0, 2-month schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"3491"},{"groupId":"OG001","value":"2140"},{"groupId":"OG002","value":"1709"},{"groupId":"OG003","value":"7430"},{"groupId":"OG004","value":"3523"},{"groupId":"OG005","value":"2166"},{"groupId":"OG006","value":"1724"},{"groupId":"OG007","value":"7413"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"8"},{"groupId":"OG005","value":"2"},{"groupId":"OG006","value":"8"},{"groupId":"OG007","value":"18"}]}]}],"analyses":[{"groupIds":["OG000","OG004"],"groupDescription":"Comparison of vaccine efficacy in prevention of PHN between GSK1437173A 50-59 YOA group and placebo 50-59 YOA group","nonInferiorityType":"OTHER","nonInferiorityComment":"Criteria for the VE objective of HZ/su vaccine against PHN in the 50-59 YOA strata: The lower limit of the 95% CI of VE had to be above 0%","pValue":"0.0081","statisticalMethod":"Poisson exact test","paramType":"Vaccine efficacy","paramValue":"100","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"40.9","ciUpperLimit":"100"},{"groupIds":["OG001","OG005"],"groupDescription":"Comparison of vaccine efficacy in prevention of PHN between GSK1437173A 60-69 YOA group and placebo 60-69 YOA group","nonInferiorityType":"OTHER","nonInferiorityComment":"Criteria for VE objective of HZ/su vaccine against PHN in the 60-69 YOA strata: The lower limit of the 95% CI of VE had to be above 0%","pValue":"0.5097","statisticalMethod":"Poisson exact test","paramType":"Vaccine efficacy","paramValue":"100","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-442.8","ciUpperLimit":"100"},{"groupIds":["OG002","OG006"],"groupDescription":"Comparison of vaccine efficacy in prevention of PHN between GSK1437173A over 70 YOA group and placebo over 70 YOA group","nonInferiorityType":"OTHER","nonInferiorityComment":"Criteria for the VE objective of HZ/su vaccine against PHN in the 70-79 YOA strata: The lower limit of the 95% CI of VE had to be above 0%","pValue":"0.0078","statisticalMethod":"Poisson exact test","paramType":"Vaccine efficacy","paramValue":"100","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"41.4","ciUpperLimit":"100"},{"groupIds":["OG003","OG007"],"groupDescription":"Comparison of vaccine efficacy in prevention of PHN between GSK1437173A overall ages group and placebo overall ages group","nonInferiorityType":"OTHER","nonInferiorityComment":"Criteria for the VE objective of HZ/su vaccine against PHN in the overall ages strata: The lower limit of the 95% CI of VE had to be above 0%","pValue":"<0.0001","statisticalMethod":"Poisson exact test","paramType":"Vaccine efficacy","paramValue":"100","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"77.1","ciUpperLimit":"100"}]},{"type":"SECONDARY","title":"Number of Subjects With a Reduction of Duration of Severe 'Worst' HZ-associated Pain","description":"Severe 'worst' pain was defined as HZ-associated pain rated as 3 or above on the 'worst pain' Zoster Brief Pain Inventory (ZBPI) questionnaire. The outcome assessed the duration of severe 'worst' HZ-associated pain following the onset of a confirmed HZ rash over the entire pain reporting period as measured by the ZBPI in subjects with confirmed HZ. This analysis involved any subject reporting clinically significant pain (i.e. pain with a score of 3 or more on a 0-10 point scale) at any time during the study.","populationDescription":"The analysis was based on the modified total vaccinated cohort, which included subjects from the total vaccinated cohort, except those who were not administered with the second vaccination or who developed a confirmed case of Herpes Zoster prior to 1 month after the second vaccination.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"During the entire study period (3 to 5 year period following Day 0)","groups":[{"id":"OG000","title":"GSK1437173A 50-59 YOA Group","description":"Subjects aged between 50 and 59 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG001","title":"GSK1437173A 60-69 YOA Group","description":"Subjects aged between 60 and 69 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG002","title":"GSK1437173A Over 70 YOA Group","description":"Subjects aged above 70 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG003","title":"GSK1437173A Overall Ages Group","description":"Subjects aged over 50 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG004","title":"Placebo 50-59 YOA Group","description":"Subjects aged between 50 and 59 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG005","title":"Placebo 60-69 YOA Group","description":"Subjects aged between 60 and 69 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG006","title":"Placebo Over 70 YOA Group","description":"Subjects aged above 70 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG007","title":"Placebo Overall Ages Group","description":"Subjects aged over 50 years of age (YOA), receiving placebo according to a 0, 2-month schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"9"},{"groupId":"OG004","value":"103"},{"groupId":"OG005","value":"90"},{"groupId":"OG006","value":"61"},{"groupId":"OG007","value":"254"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"7"},{"groupId":"OG004","value":"91"},{"groupId":"OG005","value":"74"},{"groupId":"OG006","value":"56"},{"groupId":"OG007","value":"221"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Confirmed HZ Episode Related Mortality","description":"The analysis focused on the number of subjects who died due to HZ","populationDescription":"The analysis was based on the modified total vaccinated cohort, which included subjects from the total vaccinated cohort, except those who were not administered with the second vaccination or who developed a confirmed case of Herpes Zoster prior to 1 month after the second vaccination.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"During the entire study period (3 to 5 year period following Day 0)","groups":[{"id":"OG000","title":"GSK1437173A 50-59 YOA Group","description":"Subjects aged between 50 and 59 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG001","title":"GSK1437173A 60-69 YOA Group","description":"Subjects aged between 60 and 69 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG002","title":"GSK1437173A Over 70 YOA Group","description":"Subjects aged above 70 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG003","title":"GSK1437173A Overall Ages Group","description":"Subjects aged over 50 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG004","title":"Placebo 50-59 YOA Group","description":"Subjects aged between 50 and 59 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG005","title":"Placebo 60-69 YOA Group","description":"Subjects aged between 60 and 69 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG006","title":"Placebo Over 70 YOA Group","description":"Subjects aged above 70 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG007","title":"Placebo Overall Ages Group","description":"Subjects aged over 50 years of age (YOA), receiving placebo according to a 0, 2-month schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"3491"},{"groupId":"OG001","value":"2140"},{"groupId":"OG002","value":"1709"},{"groupId":"OG003","value":"7340"},{"groupId":"OG004","value":"3523"},{"groupId":"OG005","value":"2166"},{"groupId":"OG006","value":"1724"},{"groupId":"OG007","value":"7413"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With HZ Related Complications","description":"The analysis focused on the incidence of HZ complications in subjects with confirmed HZ","populationDescription":"The analysis was based on the modified total vaccinated cohort, which included subjects from the total vaccinated cohort, except those who were not administered with the second vaccination or who developed a confirmed case of Herpes Zoster prior to 1 month after the second vaccination.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"During the entire study period (3 to 5 year period following Day 0)","groups":[{"id":"OG000","title":"GSK1437173A 50-59 YOA Group","description":"Subjects aged between 50 and 59 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG001","title":"GSK1437173A 60-69 YOA Group","description":"Subjects aged between 60 and 69 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG002","title":"GSK1437173A Over 70 YOA Group","description":"Subjects aged above 70 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG003","title":"GSK1437173A Overall Ages Group","description":"Subjects aged over 50 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG004","title":"Placebo 50-59 YOA Group","description":"Subjects aged between 50 and 59 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG005","title":"Placebo 60-69 YOA Group","description":"Subjects aged between 60 and 69 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG006","title":"Placebo Over 70 YOA Group","description":"Subjects aged above 70 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG007","title":"Placebo Overall Ages Group","description":"Subjects aged over 50 years of age (YOA), receiving placebo according to a 0, 2-month schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"9"},{"groupId":"OG004","value":"103"},{"groupId":"OG005","value":"90"},{"groupId":"OG006","value":"61"},{"groupId":"OG007","value":"254"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"3"},{"groupId":"OG006","value":"2"},{"groupId":"OG007","value":"6"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Confirmed HZ Episode Related Hospitalizations","description":"The analysis focused on confirmed HZ episode related hospitalizations.","populationDescription":"The analysis was based on the modified total vaccinated cohort, which included subjects from the total vaccinated cohort, except those who were not administered with the second vaccination or who developed a confirmed case of Herpes Zoster prior to 1 month after the second vaccination.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"During the entire study period (3 to 5 year period following Day 0)","groups":[{"id":"OG000","title":"GSK1437173A 50-59 YOA Group","description":"Subjects aged between 50 and 59 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG001","title":"GSK1437173A 60-69 YOA Group","description":"Subjects aged between 60 and 69 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG002","title":"GSK1437173A Over 70 YOA Group","description":"Subjects aged above 70 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG003","title":"GSK1437173A Overall Ages Group","description":"Subjects aged over 50 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG004","title":"Placebo 50-59 YOA Group","description":"Subjects aged between 50 and 59 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG005","title":"Placebo 60-69 YOA Group","description":"Subjects aged between 60 and 69 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG006","title":"Placebo Over 70 YOA Group","description":"Subjects aged above 70 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG007","title":"Placebo Overall Ages Group","description":"Subjects aged over 50 years of age (YOA), receiving placebo according to a 0, 2-month schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"3491"},{"groupId":"OG001","value":"2140"},{"groupId":"OG002","value":"1709"},{"groupId":"OG003","value":"7340"},{"groupId":"OG004","value":"3523"},{"groupId":"OG005","value":"2166"},{"groupId":"OG006","value":"1724"},{"groupId":"OG007","value":"7413"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With a Confirmed HZ Episode Having a Reduction of Duration of Pain Medication Associated With HZ","description":"The analysis focused on patients who experienced a reduction in duration of pain medication administered for HZ in subjects with confirmed HZ.","populationDescription":"The analysis was based on the modified total vaccinated cohort, which included subjects from the total vaccinated cohort, except those who were not administered with the second vaccination or who developed a confirmed case of Herpes Zoster prior to 1 month after the second vaccination.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"During the entire study period (3 to 5 year period following Day 0)","groups":[{"id":"OG000","title":"GSK1437173A 50-59 YOA Group","description":"Subjects aged between 50 and 59 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG001","title":"GSK1437173A 60-69 YOA Group","description":"Subjects aged between 60 and 69 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG002","title":"GSK1437173A Over 70 YOA Group","description":"Subjects aged above 70 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG003","title":"GSK1437173A Overall Ages Group","description":"Subjects aged over 50 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG004","title":"Placebo 50-59 YOA Group","description":"Subjects aged between 50 and 59 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG005","title":"Placebo 60-69 YOA Group","description":"Subjects aged between 60 and 69 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG006","title":"Placebo Over 70 YOA Group","description":"Subjects aged above 70 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG007","title":"Placebo Overall Ages Group","description":"Subjects aged over 50 years of age (YOA), receiving placebo according to a 0, 2-month schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"9"},{"groupId":"OG004","value":"103"},{"groupId":"OG005","value":"90"},{"groupId":"OG006","value":"61"},{"groupId":"OG007","value":"254"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"6"},{"groupId":"OG004","value":"82"},{"groupId":"OG005","value":"63"},{"groupId":"OG006","value":"45"},{"groupId":"OG007","value":"190"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With a Confirmed HZ Episode Taking Pain Medication Associated With HZ","description":"The analysis focused on subjects taking pain medication due to HZ","populationDescription":"The analysis was based on the modified total vaccinated cohort, which included subjects from the total vaccinated cohort, except those who were not administered with the second vaccination or who developed a confirmed case of Herpes Zoster prior to 1 month after the second vaccination.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"During the entire study period (3 to 5 year period following Day 0)","groups":[{"id":"OG000","title":"GSK1437173A 50-59 YOA Group","description":"Subjects aged between 50 and 59 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG001","title":"GSK1437173A 60-69 YOA Group","description":"Subjects aged between 60 and 69 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG002","title":"GSK1437173A Over 70 YOA Group","description":"Subjects aged above 70 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG003","title":"GSK1437173A Overall Ages Group","description":"Subjects aged over 50 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG004","title":"Placebo 50-59 YOA Group","description":"Subjects aged between 50 and 59 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG005","title":"Placebo 60-69 YOA Group","description":"Subjects aged between 60 and 69 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG006","title":"Placebo Over 70 YOA Group","description":"Subjects aged above 70 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG007","title":"Placebo Overall Ages Group","description":"Subjects aged over 50 years of age (YOA), receiving placebo according to a 0, 2-month schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"9"},{"groupId":"OG004","value":"103"},{"groupId":"OG005","value":"90"},{"groupId":"OG006","value":"61"},{"groupId":"OG007","value":"254"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"6"},{"groupId":"OG004","value":"82"},{"groupId":"OG005","value":"63"},{"groupId":"OG006","value":"45"},{"groupId":"OG007","value":"190"}]}]}]},{"type":"SECONDARY","title":"Number of Days With Severe 'Worst' HZ-associated Pain.","description":"Severe 'worst' pain was defined as HZ-associated pain rated as 3 or above on the 'worst pain' ZBPI questionnaire. This Outcome Measure was only assessed participants with confirmed HZ. This analysis involved any subject reporting ZBPI clinically significant pain (i.e. pain with a score of 3 or more on a 0-10 point scale) at any time during the study.","populationDescription":"The analysis was based on the modified total vaccinated cohort, which included subjects from the total vaccinated cohort, except those who were not administered with the second vaccination or who developed a confirmed case of Herpes Zoster prior to 1 month after the second vaccination.","reportingStatus":"POSTED","paramType":"MEAN","dispersionType":"Standard Deviation","unitOfMeasure":"Days","timeFrame":"During the entire study period (3 to 5 year period following Day 0)","groups":[{"id":"OG000","title":"GSK1437173A 50-59 YOA Group","description":"Subjects aged between 50 and 59 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG001","title":"GSK1437173A 60-69 YOA Group","description":"Subjects aged between 60 and 69 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG002","title":"GSK1437173A Over 70 YOA Group","description":"Subjects aged above 70 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG003","title":"GSK1437173A Overall Ages Group","description":"Subjects aged over 50 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG004","title":"Placebo 50-59 YOA Group","description":"Subjects aged between 50 and 59 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG005","title":"Placebo 60-69 YOA Group","description":"Subjects aged between 60 and 69 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG006","title":"Placebo Over 70 YOA Group","description":"Subjects aged above 70 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG007","title":"Placebo Overall Ages Group","description":"Subjects aged over 50 years of age (YOA), receiving placebo according to a 0, 2-month schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"7"},{"groupId":"OG004","value":"91"},{"groupId":"OG005","value":"74"},{"groupId":"OG006","value":"56"},{"groupId":"OG007","value":"221"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"12.0","spread":"11.8"},{"groupId":"OG001","value":"78.0","spread":"0.0"},{"groupId":"OG002","value":"9.0","spread":"4.2"},{"groupId":"OG003","value":"20.6","spread":"26.8"},{"groupId":"OG004","value":"28.7","spread":"48.4"},{"groupId":"OG005","value":"21.6","spread":"29.3"},{"groupId":"OG006","value":"44.0","spread":"74.4"},{"groupId":"OG007","value":"30.2","spread":"51.9"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Confirmed HZ Episode Related Mortality and Hospitalizations","description":"The analysis focused on confirmed HZ episode related hospitalizations and deaths.","populationDescription":"The analysis was based on the modified total vaccinated cohort, which included subjects from the total vaccinated cohort, except those who were not administered with the second vaccination or who developed a confirmed case of Herpes Zoster prior to 1 month after the second vaccination.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"During the entire study period (3 to 5 year period following Day 0)","groups":[{"id":"OG000","title":"GSK1437173A 50-59 YOA Group","description":"Subjects aged between 50 and 59 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG001","title":"GSK1437173A 60-69 YOA Group","description":"Subjects aged between 60 and 69 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG002","title":"GSK1437173A Over 70 YOA Group","description":"Subjects aged above 70 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG003","title":"GSK1437173A Overall Ages Group","description":"Subjects aged over 50 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG004","title":"Placebo 50-59 YOA Group","description":"Subjects aged between 50 and 59 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG005","title":"Placebo 60-69 YOA Group","description":"Subjects aged between 60 and 69 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG006","title":"Placebo Over 70 YOA Group","description":"Subjects aged above 70 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG007","title":"Placebo Overall Ages Group","description":"Subjects aged over 50 years of age (YOA), receiving placebo according to a 0, 2-month schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"3491"},{"groupId":"OG001","value":"2140"},{"groupId":"OG002","value":"1709"},{"groupId":"OG003","value":"7340"},{"groupId":"OG004","value":"3523"},{"groupId":"OG005","value":"2166"},{"groupId":"OG006","value":"1724"},{"groupId":"OG007","value":"7413"}]}],"classes":[{"title":"Mortality","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"}]}]},{"title":"Hospitalization","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"}]}]},{"title":"Mortality or hospitalization","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With HZ Related Complications, by Complication Type","description":"Complication types included HZ vasculitis, Disseminated Disease, Ophtalmic Disease, Neurologic Disease, Visceral Disease and Stroke. This Outcome Measure was only assessed participants with confirmed HZ.","populationDescription":"The analysis was based on the modified total vaccinated cohort, which included subjects from the total vaccinated cohort, except those who were not administered with the second vaccination or who developed a confirmed case of Herpes Zoster prior to 1 month after the second vaccination.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"During the entire study period (3 to 5 year period following Day 0)","groups":[{"id":"OG000","title":"GSK1437173A 50-59 YOA Group","description":"Subjects aged between 50 and 59 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG001","title":"GSK1437173A 60-69 YOA Group","description":"Subjects aged between 60 and 69 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG002","title":"GSK1437173A Over 70 YOA Group","description":"Subjects aged above 70 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG003","title":"GSK1437173A Overall Ages Group","description":"Subjects aged over 50 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG004","title":"Placebo 50-59 YOA Group","description":"Subjects aged between 50 and 59 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG005","title":"Placebo 60-69 YOA Group","description":"Subjects aged between 60 and 69 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG006","title":"Placebo Over 70 YOA Group","description":"Subjects aged above 70 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG007","title":"Placebo Overall Ages Group","description":"Subjects aged over 50 years of age (YOA), receiving placebo according to a 0, 2-month schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"9"},{"groupId":"OG004","value":"103"},{"groupId":"OG005","value":"90"},{"groupId":"OG006","value":"61"},{"groupId":"OG007","value":"254"}]}],"classes":[{"title":"At least one complication","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"3"},{"groupId":"OG006","value":"2"},{"groupId":"OG007","value":"6"}]}]},{"title":"HZ vasculitis","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"1"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"1"}]}]},{"title":"Disseminated Disease","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"1"},{"groupId":"OG006","value":"2"},{"groupId":"OG007","value":"4"}]}]},{"title":"Ophtalmic Disease","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"1"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"1"}]}]},{"title":"Neurologic Disease","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"}]}]},{"title":"Visceral Disease","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"}]}]},{"title":"Stroke","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"}]}]}]},{"type":"SECONDARY","title":"Distribution of Pain Medication Associated With HZ","description":"The distribution of pain medication included 1 to 3 or more separate medications. This Outcome Measure was only assessed on participants with confirmed HZ.","populationDescription":"The analysis was based on the modified total vaccinated cohort, which included subjects from the total vaccinated cohort, except those who were not administered with the second vaccination or who developed a confirmed case of Herpes Zoster prior to 1 month after the second vaccination.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"During the entire study period (3 to 5 year period following Day 0)","groups":[{"id":"OG000","title":"GSK1437173A 50-59 YOA Group","description":"Subjects aged between 50 and 59 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG001","title":"GSK1437173A 60-69 YOA Group","description":"Subjects aged between 60 and 69 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG002","title":"GSK1437173A Over 70 YOA Group","description":"Subjects aged above 70 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG003","title":"GSK1437173A Overall Ages Group","description":"Subjects aged over 50 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG004","title":"Placebo 50-59 YOA Group","description":"Subjects aged between 50 and 59 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG005","title":"Placebo 60-69 YOA Group","description":"Subjects aged between 60 and 69 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG006","title":"Placebo Over 70 YOA Group","description":"Subjects aged above 70 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG007","title":"Placebo Overall Ages Group","description":"Subjects aged over 50 years of age (YOA), receiving placebo according to a 0, 2-month schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"9"},{"groupId":"OG004","value":"103"},{"groupId":"OG005","value":"90"},{"groupId":"OG006","value":"61"},{"groupId":"OG007","value":"254"}]}],"classes":[{"title":"At least one pain medication","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"6"},{"groupId":"OG004","value":"82"},{"groupId":"OG005","value":"63"},{"groupId":"OG006","value":"45"},{"groupId":"OG007","value":"190"}]}]},{"title":"1 pain medication only","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"30"},{"groupId":"OG005","value":"23"},{"groupId":"OG006","value":"14"},{"groupId":"OG007","value":"67"}]}]},{"title":"2 pain medications only","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"26"},{"groupId":"OG005","value":"19"},{"groupId":"OG006","value":"9"},{"groupId":"OG007","value":"54"}]}]},{"title":"3 pain medications or more","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"26"},{"groupId":"OG005","value":"21"},{"groupId":"OG006","value":"22"},{"groupId":"OG007","value":"69"}]}]}]},{"type":"SECONDARY","title":"Number of Days of Pain Medication Associated With HZ","description":"The analysis was performed on subjects with a confirmed HZ episode","populationDescription":"The analysis was based on the modified total vaccinated cohort, which included subjects from the total vaccinated cohort, except those who were not administered with the second vaccination or who developed a confirmed case of Herpes Zoster prior to 1 month after the second vaccination.","reportingStatus":"POSTED","paramType":"MEAN","dispersionType":"Standard Deviation","unitOfMeasure":"Days","timeFrame":"During the entire study period (3 to 5 year period following Day 0)","groups":[{"id":"OG000","title":"GSK1437173A 50-59 YOA Group","description":"Subjects aged between 50 and 59 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG001","title":"GSK1437173A 60-69 YOA Group","description":"Subjects aged between 60 and 69 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG002","title":"GSK1437173A Over 70 YOA Group","description":"Subjects aged above 70 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG003","title":"GSK1437173A Overall Ages Group","description":"Subjects aged over 50 years of age (YOA), receiving the GSK1437173A vaccine according to a 0, 2-month schedule."},{"id":"OG004","title":"Placebo 50-59 YOA Group","description":"Subjects aged between 50 and 59 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG005","title":"Placebo 60-69 YOA Group","description":"Subjects aged between 60 and 69 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG006","title":"Placebo Over 70 YOA Group","description":"Subjects aged above 70 years of age (YOA), receiving placebo according to a 0, 2-month schedule."},{"id":"OG007","title":"Placebo Overall Ages Group","description":"Subjects aged over 50 years of age (YOA), receiving placebo according to a 0, 2-month schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"6"},{"groupId":"OG004","value":"82"},{"groupId":"OG005","value":"63"},{"groupId":"OG006","value":"45"},{"groupId":"OG007","value":"190"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"17.3","spread":"14.5"},{"groupId":"OG001","value":"20.5","spread":"16.3"},{"groupId":"OG002","value":"63.0","spread":"0.0"},{"groupId":"OG003","value":"26.0","spread":"21.6"},{"groupId":"OG004","value":"49.2","spread":"121.5"},{"groupId":"OG005","value":"74.3","spread":"166.3"},{"groupId":"OG006","value":"127.7","spread":"266.9"},{"groupId":"OG007","value":"76.1","spread":"181.5"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Any and Grade 3 Solicited Local Symptoms","description":"Assessed solicited local symptoms were pain, redness and swelling. Any = occurrence of the symptom regardless of intensity grade. Grade 3 pain = Significant pain at rest that prevented normal activity. Grade 3 redness/swelling = redness/swelling spreading beyond 100 millimeters (mm) of injection site. Relationship analysis was not performed.","populationDescription":"The analysis was performed on the total vaccinated cohort - Diary Card, which was a subset of subjects from the total vaccinated cohort, who completed diary cards with any solicited symptoms during the 7 days (Day 0 to Day 6) post vaccination period.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"During the 7-day (Days 0-6) post-vaccination period","groups":[{"id":"OG000","title":"GSK1437173A Group","description":"Subjects received herpes zoster subunit vaccine (gE/AS01B vaccine: GSK1437173A) according to a 0, 2-month schedule."},{"id":"OG001","title":"Placebo Group","description":"Subjects received saline solution (NaCl solution) as control according to a 0, 2-month schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4379"},{"groupId":"OG001","value":"4375"}]}],"classes":[{"title":"Any Pain, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4359"},{"groupId":"OG001","value":"4361"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3120"},{"groupId":"OG001","value":"352"}]}]},{"title":"Grade 3 Pain, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4359"},{"groupId":"OG001","value":"4361"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"159"},{"groupId":"OG001","value":"6"}]}]},{"title":"Any Redness, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4359"},{"groupId":"OG001","value":"4361"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1225"},{"groupId":"OG001","value":"40"}]}]},{"title":"Grade 3 Redness, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4359"},{"groupId":"OG001","value":"4361"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"82"},{"groupId":"OG001","value":"0"}]}]},{"title":"Any Swelling, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4359"},{"groupId":"OG001","value":"4361"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"810"},{"groupId":"OG001","value":"31"}]}]},{"title":"Grade 3 Swelling, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4359"},{"groupId":"OG001","value":"4361"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"0"}]}]},{"title":"Any Pain, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4207"},{"groupId":"OG001","value":"4224"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2807"},{"groupId":"OG001","value":"258"}]}]},{"title":"Grade 3 Pain, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4207"},{"groupId":"OG001","value":"4224"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"185"},{"groupId":"OG001","value":"10"}]}]},{"title":"Any Redness, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4207"},{"groupId":"OG001","value":"4224"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1151"},{"groupId":"OG001","value":"24"}]}]},{"title":"Grade 3 Redness, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4207"},{"groupId":"OG001","value":"4224"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"56"},{"groupId":"OG001","value":"0"}]}]},{"title":"Any Swelling, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4207"},{"groupId":"OG001","value":"4224"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"762"},{"groupId":"OG001","value":"17"}]}]},{"title":"Grade 3 Swelling, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4207"},{"groupId":"OG001","value":"4224"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"0"}]}]},{"title":"Any Pain, Overall","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4379"},{"groupId":"OG001","value":"4375"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3463"},{"groupId":"OG001","value":"490"}]}]},{"title":"Grade 3 Pain, Overall","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4379"},{"groupId":"OG001","value":"4375"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"293"},{"groupId":"OG001","value":"16"}]}]},{"title":"Any Redness, Overall","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4379"},{"groupId":"OG001","value":"4375"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1665"},{"groupId":"OG001","value":"59"}]}]},{"title":"Grade 3 Redness, Overall","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4379"},{"groupId":"OG001","value":"4375"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"121"},{"groupId":"OG001","value":"0"}]}]},{"title":"Any Swelling, Overall","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4379"},{"groupId":"OG001","value":"4375"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1153"},{"groupId":"OG001","value":"46"}]}]},{"title":"Grade 3 Swelling, Overall","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4379"},{"groupId":"OG001","value":"4375"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"43"},{"groupId":"OG001","value":"0"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Any, Grade 3 and Related Solicited General Symptoms","description":"Assessed solicited general symptoms were fatigue, GI (gastrointestinal) symptoms (included nausea, vomiting, diarrhoea and/or abdominal pain), fever \\[defined as oral, axillary, rectal or tympanic temperature equal to or above 37.5 degrees Celsius (°C)\\], headache, myalgia, shivering and sweating. Any = occurrence of the symptom regardless of intensity grade. Grade 3 symptom = symptom that prevented normal activity. Grade 3 fever = temperature\\> 39.0 °C. Related = symptom assessed by the investigator as related to the vaccination.","populationDescription":"The analysis was performed on the TVc - Diary Card, which was a subset of subjects from the TVc, who completed diary cards with any solicited symptoms during the 7 days (Day 0 to Day 6) post vaccination period.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Within the 7-day (Days 0-6) post-vaccination period","groups":[{"id":"OG000","title":"GSK1437173A Group","description":"Subjects received herpes zoster subunit vaccine (gE/AS01B vaccine: GSK1437173A) according to a 0, 2-month schedule."},{"id":"OG001","title":"Placebo Group","description":"Subjects received saline solution (NaCl solution) as control according to a 0, 2-month schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4372"},{"groupId":"OG001","value":"4376"}]}],"classes":[{"title":"Any Fatigue, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4346"},{"groupId":"OG001","value":"4362"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1395"},{"groupId":"OG001","value":"531"}]}]},{"title":"Grade 3 Fatigue, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4346"},{"groupId":"OG001","value":"4362"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"109"},{"groupId":"OG001","value":"29"}]}]},{"title":"Related fatigue, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4346"},{"groupId":"OG001","value":"4362"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1153"},{"groupId":"OG001","value":"355"}]}]},{"title":"Any GI symptoms, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4346"},{"groupId":"OG001","value":"4362"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"465"},{"groupId":"OG001","value":"263"}]}]},{"title":"Grade 3 GI symptoms, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4346"},{"groupId":"OG001","value":"4362"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"12"}]}]},{"title":"Related GI symptoms, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4346"},{"groupId":"OG001","value":"4362"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"317"},{"groupId":"OG001","value":"141"}]}]},{"title":"Any Headache, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4346"},{"groupId":"OG001","value":"4362"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1112"},{"groupId":"OG001","value":"511"}]}]},{"title":"Grade 3 Headache, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4346"},{"groupId":"OG001","value":"4362"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"67"},{"groupId":"OG001","value":"20"}]}]},{"title":"Related Headache, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4346"},{"groupId":"OG001","value":"4362"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"891"},{"groupId":"OG001","value":"341"}]}]},{"title":"Any Myalgia, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4346"},{"groupId":"OG001","value":"4362"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1446"},{"groupId":"OG001","value":"377"}]}]},{"title":"Grade 3 Myalgia, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4346"},{"groupId":"OG001","value":"4362"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"104"},{"groupId":"OG001","value":"21"}]}]},{"title":"Related Myalgia, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4346"},{"groupId":"OG001","value":"4362"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1231"},{"groupId":"OG001","value":"265"}]}]},{"title":"Any Shivering, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4346"},{"groupId":"OG001","value":"4362"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"632"},{"groupId":"OG001","value":"166"}]}]},{"title":"Grade 3 Shivering, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4346"},{"groupId":"OG001","value":"4362"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"3"}]}]},{"title":"Related Shivering, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4346"},{"groupId":"OG001","value":"4362"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"539"},{"groupId":"OG001","value":"104"}]}]},{"title":"Any Temperature, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4346"},{"groupId":"OG001","value":"4362"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"500"},{"groupId":"OG001","value":"65"}]}]},{"title":"Grade 3 Temperature, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4346"},{"groupId":"OG001","value":"4362"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"1"}]}]},{"title":"Related Temperature, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4346"},{"groupId":"OG001","value":"4362"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"420"},{"groupId":"OG001","value":"38"}]}]},{"title":"Any Fatigue, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4205"},{"groupId":"OG001","value":"4222"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1456"},{"groupId":"OG001","value":"379"}]}]},{"title":"Grade 3 Fatigue, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4205"},{"groupId":"OG001","value":"4222"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"157"},{"groupId":"OG001","value":"18"}]}]},{"title":"Related fatigue, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4205"},{"groupId":"OG001","value":"4222"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1270"},{"groupId":"OG001","value":"279"}]}]},{"title":"Any GI symptoms, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4205"},{"groupId":"OG001","value":"4222"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"495"},{"groupId":"OG001","value":"183"}]}]},{"title":"Grade 3 GI symptoms, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4205"},{"groupId":"OG001","value":"4222"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"14"}]}]},{"title":"Related GI symptoms, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4205"},{"groupId":"OG001","value":"4222"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"392"},{"groupId":"OG001","value":"91"}]}]},{"title":"Any Headache, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4205"},{"groupId":"OG001","value":"4222"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1249"},{"groupId":"OG001","value":"340"}]}]},{"title":"Grade 3 Headache, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4205"},{"groupId":"OG001","value":"4222"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"105"},{"groupId":"OG001","value":"13"}]}]},{"title":"Related Headache, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4205"},{"groupId":"OG001","value":"4222"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1107"},{"groupId":"OG001","value":"219"}]}]},{"title":"Any Myalgia, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4205"},{"groupId":"OG001","value":"4222"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1474"},{"groupId":"OG001","value":"274"}]}]},{"title":"Grade 3 Myalgia, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4205"},{"groupId":"OG001","value":"4222"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"160"},{"groupId":"OG001","value":"13"}]}]},{"title":"Related Myalgia, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4205"},{"groupId":"OG001","value":"4222"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1314"},{"groupId":"OG001","value":"197"}]}]},{"title":"Any Shivering, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4205"},{"groupId":"OG001","value":"4222"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"947"},{"groupId":"OG001","value":"128"}]}]},{"title":"Grade 3 Shivering, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4205"},{"groupId":"OG001","value":"4222"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"139"},{"groupId":"OG001","value":"9"}]}]},{"title":"Related Shivering, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4205"},{"groupId":"OG001","value":"4222"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"838"},{"groupId":"OG001","value":"88"}]}]},{"title":"Any Temperature, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4205"},{"groupId":"OG001","value":"4222"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"645"},{"groupId":"OG001","value":"72"}]}]},{"title":"Grade 3 Temperature, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4205"},{"groupId":"OG001","value":"4222"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"5"}]}]},{"title":"Related Temperature, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4205"},{"groupId":"OG001","value":"4222"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"571"},{"groupId":"OG001","value":"40"}]}]},{"title":"Any Fatigue, Overall","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4372"},{"groupId":"OG001","value":"4376"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2006"},{"groupId":"OG001","value":"728"}]}]},{"title":"Grade 3 Fatigue, Overall","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4372"},{"groupId":"OG001","value":"4376"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"241"},{"groupId":"OG001","value":"46"}]}]},{"title":"Related fatigue, Overall","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4372"},{"groupId":"OG001","value":"4376"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1724"},{"groupId":"OG001","value":"522"}]}]},{"title":"Any GI symptoms, Overall","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4372"},{"groupId":"OG001","value":"4376"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"787"},{"groupId":"OG001","value":"386"}]}]},{"title":"Grade 3 GI symptoms, Overall","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4372"},{"groupId":"OG001","value":"4376"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"61"},{"groupId":"OG001","value":"25"}]}]},{"title":"Related GI symptoms, Overall","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4372"},{"groupId":"OG001","value":"4376"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"591"},{"groupId":"OG001","value":"206"}]}]},{"title":"Any Headache, Overall","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4372"},{"groupId":"OG001","value":"4376"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1714"},{"groupId":"OG001","value":"700"}]}]},{"title":"Grade 3 Headache, Overall","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4372"},{"groupId":"OG001","value":"4376"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"157"},{"groupId":"OG001","value":"30"}]}]},{"title":"Related Headache, Overall","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4372"},{"groupId":"OG001","value":"4376"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1470"},{"groupId":"OG001","value":"469"}]}]},{"title":"Any Myalgia, Overall","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4372"},{"groupId":"OG001","value":"4376"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2023"},{"groupId":"OG001","value":"529"}]}]},{"title":"Grade 3 Myalgia, Overall","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4372"},{"groupId":"OG001","value":"4376"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"236"},{"groupId":"OG001","value":"31"}]}]},{"title":"Related Myalgia, Overall","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4372"},{"groupId":"OG001","value":"4376"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1791"},{"groupId":"OG001","value":"390"}]}]},{"title":"Any Shivering, Overall","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4372"},{"groupId":"OG001","value":"4376"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1232"},{"groupId":"OG001","value":"259"}]}]},{"title":"Grade 3 Shivering, Overall","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4372"},{"groupId":"OG001","value":"4376"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"192"},{"groupId":"OG001","value":"11"}]}]},{"title":"Related Shivering, Overall","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4372"},{"groupId":"OG001","value":"4376"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1082"},{"groupId":"OG001","value":"177"}]}]},{"title":"Any Temperature, Overall","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4372"},{"groupId":"OG001","value":"4376"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"940"},{"groupId":"OG001","value":"132"}]}]},{"title":"Grade 3 Temperature, Overall","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4372"},{"groupId":"OG001","value":"4376"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"6"}]}]},{"title":"Related Temperature, Overall","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4372"},{"groupId":"OG001","value":"4376"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"813"},{"groupId":"OG001","value":"78"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Any and Grade 3 Symptoms (Solicited and Unsolicited)","description":"Number of subjects with any and grade 3 solicited and unsolicited symptoms were tabulated","populationDescription":"The analysis was performed on the total vaccinated cohort - Diary Card, which was a subset of subjects from the total vaccinated cohort, who completed diary cards with any solicited symptoms during the 7 days (Day 0 to Day 6) post vaccination period.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Within the 7-day (Days 0-6) post-vaccination period","groups":[{"id":"OG000","title":"GSK1437173A Group","description":"Subjects received herpes zoster subunit vaccine (gE/AS01B vaccine: GSK1437173A) according to a 0, 2-month schedule."},{"id":"OG001","title":"Placebo Group","description":"Subjects received saline solution (NaCl solution) as control according to a 0, 2-month schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4457"},{"groupId":"OG001","value":"4464"}]}],"classes":[{"title":"Any solicited or unsolicited symptoms","categories":[{"measurements":[{"groupId":"OG000","value":"3766"},{"groupId":"OG001","value":"1691"}]}]},{"title":"Grade 3 solicited or unsolicited symptoms","categories":[{"measurements":[{"groupId":"OG000","value":"759"},{"groupId":"OG001","value":"145"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Any and Related Potential Immune Mediated Diseases (pIMDs)","description":"Occurrence and relationship to vaccination of any potential immune-mediated diseases (pIMDs) in all subjects","populationDescription":"This analysis was based on the the total vaccinated cohort, which included all subjects with at least one dose of study vaccine or placebo administered.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"During the entire study period (3 to 5 year period following Day 0)","groups":[{"id":"OG000","title":"GSK1437173A Group","description":"Subjects received herpes zoster subunit vaccine (gE/AS01B vaccine: GSK1437173A) according to a 0, 2-month schedule."},{"id":"OG001","title":"Placebo Group","description":"Subjects received saline solution (NaCl solution) as control according to a 0, 2-month schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"7695"},{"groupId":"OG001","value":"7710"}]}],"classes":[{"title":"Any pIMDs","categories":[{"measurements":[{"groupId":"OG000","value":"87"},{"groupId":"OG001","value":"105"}]}]},{"title":"Related pIMDs","categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"12"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With AEs With Any and Related Medically Attended Visit","description":"Occurrence and relationship to vaccination of medically attended visits (defined as hospitalizations, emergency room visits or visits to or from medical personnel), other than routine health care visits in all subjects.","populationDescription":"This analysis was based on the the total vaccinated cohort, which included all subjects with at least one dose of study vaccine or placebo administered.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From Month 0 to Month 8 post-vaccination","groups":[{"id":"OG000","title":"GSK1437173A Group","description":"Subjects received herpes zoster subunit vaccine (gE/AS01B vaccine: GSK1437173A) according to a 0, 2-month schedule."},{"id":"OG001","title":"Placebo Group","description":"Subjects received saline solution (NaCl solution) as control according to a 0, 2-month schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"7695"},{"groupId":"OG001","value":"7710"}]}],"classes":[{"title":"Any medically attended visits","categories":[{"measurements":[{"groupId":"OG000","value":"2952"},{"groupId":"OG001","value":"3072"}]}]},{"title":"Related medically attended visits","categories":[{"measurements":[{"groupId":"OG000","value":"142"},{"groupId":"OG001","value":"60"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Unsolicited Adverse Events (AEs)","description":"Occurrence, intensity and relationship to vaccination of unsolicited AEs, according to the Medical Dictionary for Regulatory Activities (MedDRA) classification in all subjects An unsolicited AE covers any untoward medical occurrence in a clinical investigation subject temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product and reported in addition to those solicited during the clinical study and any solicited symptom with onset outside the specified period of follow-up for solicited symptoms. Any was defined as the occurrence of any unsolicited AE regardless of intensity grade or relation to vaccination. Grade 3 AE = an AE which prevented normal, everyday activities. Related = AE assessed by the investigator as related to the vaccination.","populationDescription":"This analysis was based on the the total vaccinated cohort, which included all subjects with at least one dose of study vaccine or placebo administered.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Within 30 days (Days 0 - 29) after each vaccination","groups":[{"id":"OG000","title":"GSK1437173A Group","description":"Subjects received herpes zoster subunit vaccine (gE/AS01B vaccine: GSK1437173A) according to a 0, 2-month schedule."},{"id":"OG001","title":"Placebo Group","description":"Subjects received saline solution (NaCl solution) as control according to a 0, 2-month schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"7695"},{"groupId":"OG001","value":"7710"}]}],"classes":[{"title":"Any unsolicited AEs","categories":[{"measurements":[{"groupId":"OG000","value":"3534"},{"groupId":"OG001","value":"2426"}]}]},{"title":"Grade 3 unsolicited AEs","categories":[{"measurements":[{"groupId":"OG000","value":"609"},{"groupId":"OG001","value":"298"}]}]},{"title":"Related unsolicited AEs","categories":[{"measurements":[{"groupId":"OG000","value":"2199"},{"groupId":"OG001","value":"439"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Serious Adverse Events (SAEs)","description":"Occurrence and relationship to vaccination of all SAEs in all subjects. Serious adverse events (SAEs) assessed include medical occurrences that result in death, are life threatening, require hospitalization or prolongation of hospitalization or result in disability/incapacity.","populationDescription":"This analysis was based on the the total vaccinated cohort, which included all subjects with at least one dose of study vaccine or placebo administered.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Within the 30-day (Days 0-29) post-vaccination period, up to Month 14 and up to study end (3 to 5 year period following Day 0)","groups":[{"id":"OG000","title":"GSK1437173A Group","description":"Subjects received herpes zoster subunit vaccine (gE/AS01B vaccine: GSK1437173A) according to a 0, 2-month schedule."},{"id":"OG001","title":"Placebo Group","description":"Subjects received saline solution (NaCl solution) as control according to a 0, 2-month schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"7695"},{"groupId":"OG001","value":"7710"}]}],"classes":[{"title":"Any SAEs (up to Day 30)","categories":[{"measurements":[{"groupId":"OG000","value":"88"},{"groupId":"OG001","value":"97"}]}]},{"title":"Related SAEs (up to Day 30)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"3"}]}]},{"title":"Any SAEs (up to Month 14)","categories":[{"measurements":[{"groupId":"OG000","value":"594"},{"groupId":"OG001","value":"590"}]}]},{"title":"Related SAEs (up to Month 14)","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"6"}]}]},{"title":"Any SAEs (up to study end)","categories":[{"measurements":[{"groupId":"OG000","value":"727"},{"groupId":"OG001","value":"731"}]}]},{"title":"Related SAEs (up to study end)","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"7"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With SAEs Related to Study Participation or to a Concurrent GSK Medication/Vaccine","description":"The number of subjects with SAEs related to study participation or to a concurrent GSK medication/vaccine were tabulated","populationDescription":"The analysis was based on TVC, which included all subjects with at least one dose of the study vaccine or place administered.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"During the entire study period (3 to 5 year period following Day 0)","groups":[{"id":"OG000","title":"GSK1437173A Group","description":"Subjects received herpes zoster subunit vaccine (gE/AS01B vaccine: GSK1437173A) according to a 0, 2-month schedule."},{"id":"OG001","title":"Placebo Group","description":"Subjects received saline solution (NaCl solution) as control according to a 0, 2-month schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"7695"},{"groupId":"OG001","value":"7710"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"43"},{"groupId":"OG001","value":"25"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Fatal SAEs","description":"Number of subjects with fatal SAEs during the entire study period were tabulated","populationDescription":"This analysis was based on the the total vaccinated cohort, which included all subjects with at least one dose of study vaccine or placebo administered.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"During the entire study period (3 to 5 years following day 0)","groups":[{"id":"OG000","title":"GSK1437173A Group","description":"Subjects received herpes zoster subunit vaccine (gE/AS01B vaccine: GSK1437173A) according to a 0, 2-month schedule."},{"id":"OG001","title":"Placebo Group","description":"Subjects received saline solution (NaCl solution) as control according to a 0, 2-month schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"7695"},{"groupId":"OG001","value":"7710"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"208"},{"groupId":"OG001","value":"221"}]}]}]}]},"adverseEventsModule":{"frequencyThreshold":"5","timeFrame":"Solicited symptoms: within 7 days post-vaccination Unsolicited AEs: within 30 days post vaccination SAEs: during the entire study period (3 to 5 year period following Day 0)","eventGroups":[{"id":"EG000","title":"GSK1437173A Group","description":"Subjects received herpes zoster subunit vaccine (gE/AS01B vaccine: GSK1437173A) according to a 0, 2-month schedule.","deathsNumAffected":11,"deathsNumAtRisk":7695,"seriousNumAffected":727,"seriousNumAtRisk":7695,"otherNumAffected":5586,"otherNumAtRisk":7695},{"id":"EG001","title":"Placebo Group","description":"Subjects received saline solution (NaCl solution) as control according to a 0, 2-month schedule.","deathsNumAffected":15,"deathsNumAtRisk":7710,"seriousNumAffected":731,"seriousNumAtRisk":7710,"otherNumAffected":1893,"otherNumAtRisk":7710}],"seriousEvents":[{"term":"Anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":7695},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":7710}]},{"term":"Anaemia vitamin b12 deficiency","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Disseminated intravascular coagulation","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Haemorrhagic anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Heparin-induced thrombocytopenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Hypochromic anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Immune thrombocytopenic purpura","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Iron deficiency anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Lymphadenopathy","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Lymphadenopathy mediastinal","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Splenic haemorrhage","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Splenic infarction","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Thrombocytopenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Acute coronary syndrome","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Acute myocardial infarction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":8,"numAffected":8,"numAtRisk":7695},{"groupId":"EG001","numEvents":19,"numAffected":19,"numAtRisk":7710}]},{"term":"Angina pectoris","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":7710}]},{"term":"Angina unstable","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":7710}]},{"term":"Aortic valve disease","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Aortic valve stenosis","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Arrhythmia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Atrial fibrillation","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":23,"numAffected":19,"numAtRisk":7695},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":7710}]},{"term":"Atrial flutter","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":7695},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":7710}]},{"term":"Atrial tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Atrioventricular block","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Atrioventricular block complete","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Atrioventricular block second degree","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Bradyarrhythmia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Bradycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Cardiac arrest","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":8,"numAffected":8,"numAtRisk":7695},{"groupId":"EG001","numEvents":8,"numAffected":8,"numAtRisk":7710}]},{"term":"Cardiac failure","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":21,"numAffected":20,"numAtRisk":7695},{"groupId":"EG001","numEvents":27,"numAffected":24,"numAtRisk":7710}]},{"term":"Cardiac failure acute","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":7710}]},{"term":"Cardiac failure chronic","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Cardiac failure congestive","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":15,"numAffected":14,"numAtRisk":7695},{"groupId":"EG001","numEvents":10,"numAffected":10,"numAtRisk":7710}]},{"term":"Cardiac valve disease","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Cardio-respiratory arrest","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Cardiogenic shock","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Cardiomyopathy alcoholic","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Cardiopulmonary failure","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Cardiovascular deconditioning","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Cardiovascular insufficiency","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Cor pulmonale","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Coronary artery disease","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":11,"numAffected":11,"numAtRisk":7695},{"groupId":"EG001","numEvents":19,"numAffected":17,"numAtRisk":7710}]},{"term":"Coronary artery insufficiency","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Coronary artery occlusion","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Coronary artery stenosis","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Intracardiac thrombus","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Left ventricular failure","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Mitral valve prolapse","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Mitral valve stenosis","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Myocardial infarction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":28,"numAffected":28,"numAtRisk":7695},{"groupId":"EG001","numEvents":27,"numAffected":27,"numAtRisk":7710}]},{"term":"Myocardial ischaemia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":7,"numAtRisk":7695},{"groupId":"EG001","numEvents":11,"numAffected":11,"numAtRisk":7710}]},{"term":"Palpitations","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Pericardial effusion","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Pericarditis","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Right ventricular failure","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Sinus node dysfunction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Stress cardiomyopathy","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Supraventricular tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Ventricular extrasystoles","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Ventricular fibrillation","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Ventricular tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Cystic fibrosis","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Hernia congenital","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Hydrocele","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Hypertrophic cardiomyopathy","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Odontogenic cyst","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Deafness neurosensory","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Motion sickness","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Vertigo","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":7695},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":7710}]},{"term":"Vertigo positional","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Basedow's disease","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Goitre","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Hypopituitarism","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Thyroiditis subacute","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Amaurosis fugax","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Cataract","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":7710}]},{"term":"Eyelid ptosis","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Glaucoma","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Lens dislocation","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Macular cyst","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Macular hole","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Neovascular age-related macular degeneration","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Retinal artery occlusion","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Retinal detachment","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":7710}]},{"term":"Retinal tear","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Vitreous detachment","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Vitreous haemorrhage","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Abdominal hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Abdominal pain","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Abdominal pain upper","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Abdominal strangulated hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Ascites","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Colitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Colitis ischaemic","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":7710}]},{"term":"Constipation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Crohn's disease","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Diarrhoea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Diverticulum","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Diverticulum intestinal","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Duodenal perforation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Duodenal ulcer haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Duodenitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Enteritis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Enterovesical fistula","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Functional gastrointestinal disorder","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Gastric haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Gastric mucosal lesion","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Gastric polyps","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Gastric ulcer","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":7710}]},{"term":"Gastric ulcer haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Gastritis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":7695},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":7710}]},{"term":"Gastritis alcoholic","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Gastrointestinal angiodysplasia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Gastrointestinal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":7710}]},{"term":"Gastrointestinal polyp haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Gastrooesophageal reflux disease","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Gingival disorder","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Haemorrhoidal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Haemorrhoids","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":7710}]},{"term":"Hiatus hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":7710}]},{"term":"Ileus","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":7710}]},{"term":"Incarcerated umbilical hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Inguinal hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":8,"numAffected":8,"numAtRisk":7710}]},{"term":"Intestinal congestion","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Intestinal obstruction","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":7710}]},{"term":"Intestinal polyp","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Irritable bowel syndrome","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Large intestine polyp","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":7710}]},{"term":"Mallory-weiss syndrome","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Melaena","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Nausea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Oesophageal ulcer","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Oesophageal varices haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Oesophagitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Pancreatic cyst","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Pancreatic fistula","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Pancreatitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Pancreatitis acute","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":7695},{"groupId":"EG001","numEvents":7,"numAffected":6,"numAtRisk":7710}]},{"term":"Pancreatitis necrotising","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Peptic ulcer","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Peptic ulcer perforation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Periodontal disease","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Peritoneal cyst","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Peritoneal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Pneumoperitoneum","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Portal hypertensive gastropathy","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Rectal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Rectal polyp","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Retroperitoneal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Small intestinal obstruction","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":7710}]},{"term":"Splenic artery aneurysm","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Subileus","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Thrombosis mesenteric vessel","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Upper gastrointestinal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Volvulus","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Vomiting","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Asthenia","organSystem":"General disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Chest discomfort","organSystem":"General disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Chest pain","organSystem":"General disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":12,"numAffected":12,"numAtRisk":7695},{"groupId":"EG001","numEvents":12,"numAffected":10,"numAtRisk":7710}]},{"term":"Death","organSystem":"General disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":11,"numAffected":11,"numAtRisk":7695},{"groupId":"EG001","numEvents":15,"numAffected":15,"numAtRisk":7710}]},{"term":"Device dislocation","organSystem":"General disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Device failure","organSystem":"General disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Drowning","organSystem":"General disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Drug withdrawal syndrome","organSystem":"General disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"General physical health deterioration","organSystem":"General disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Gravitational oedema","organSystem":"General disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Hernia","organSystem":"General disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Impaired healing","organSystem":"General disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Influenza like illness","organSystem":"General disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Malaise","organSystem":"General disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Multi-organ failure","organSystem":"General disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Non-cardiac chest pain","organSystem":"General disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Pain","organSystem":"General disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Peripheral swelling","organSystem":"General disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Polyp","organSystem":"General disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Pyrexia","organSystem":"General disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Strangulated hernia","organSystem":"General disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Sudden cardiac death","organSystem":"General disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":7710}]},{"term":"Sudden death","organSystem":"General disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":7695},{"groupId":"EG001","numEvents":7,"numAffected":7,"numAtRisk":7710}]},{"term":"Systemic inflammatory response syndrome","organSystem":"General disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Bile duct obstruction","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Bile duct stenosis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Bile duct stone","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":7710}]},{"term":"Biliary colic","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Cholangitis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Cholangitis acute","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Cholecystitis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":7695},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":7710}]},{"term":"Cholecystitis acute","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":7695},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":7710}]},{"term":"Cholelithiasis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":7,"numAtRisk":7695},{"groupId":"EG001","numEvents":10,"numAffected":10,"numAtRisk":7710}]},{"term":"Fatty liver alcoholic","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Gallbladder polyp","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Hepatic cirrhosis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Hepatic failure","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Hepatotoxicity","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Jaundice cholestatic","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Biliary dyskinesia","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Anaphylactic reaction","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Drug hypersensitivity","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Hypersensitivity","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Sarcoidosis","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Abdominal infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Abdominal sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Abscess neck","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Anal abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Appendiceal abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Appendicitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":7710}]},{"term":"Appendicitis perforated","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Atypical pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Bacteraemia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Bacterial infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Bacteriuria","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Biliary sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Breast abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Bronchitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":7710}]},{"term":"Bronchitis bacterial","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Bronchopneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Candiduria","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Catheter site infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Cellulitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":8,"numAffected":8,"numAtRisk":7695},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":7710}]},{"term":"Cellulitis orbital","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Cellulitis streptococcal","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Chronic sinusitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Clostridium difficile colitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Clostridium difficile infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":7710}]},{"term":"Cystitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Cystitis klebsiella","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Dengue fever","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Diabetic gangrene","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Diverticulitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":7695},{"groupId":"EG001","numEvents":7,"numAffected":6,"numAtRisk":7710}]},{"term":"Encephalomyelitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Endocarditis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Endometritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Erysipelas","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":7710}]},{"term":"Fungaemia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Gangrene","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Gastroenteritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":7710}]},{"term":"Gastroenteritis caliciviral","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Gastroenteritis clostridial","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Gastroenteritis salmonella","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Gastroenteritis viral","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Gastrointestinal infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Helicobacter gastritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Hepatitis a","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Herpes zoster","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Infected dermal cyst","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Infected skin ulcer","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Infectious colitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Influenza","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Klebsiella sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Labyrinthitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Leptospirosis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Liver abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Lobar pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Localised infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Lower respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":7710}]},{"term":"Lung infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Lymph node tuberculosis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Meningitis pneumococcal","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Mycobacterial infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Nasal abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Nasopharyngitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Neuroborreliosis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Osteomyelitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":4,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Osteomyelitis chronic","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Otitis media chronic","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Periodontitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Peritonitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Peritonsillar abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Pertussis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Pharyngitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Pharyngotonsillitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":41,"numAffected":40,"numAtRisk":7695},{"groupId":"EG001","numEvents":28,"numAffected":26,"numAtRisk":7710}]},{"term":"Pneumonia bacterial","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Pneumonia mycoplasmal","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Pneumonia pneumococcal","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Post procedural infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":7710}]},{"term":"Pseudomembranous colitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Pyelonephritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":7695},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":7710}]},{"term":"Pyelonephritis acute","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":7,"numAtRisk":7695},{"groupId":"EG001","numEvents":14,"numAffected":13,"numAtRisk":7710}]},{"term":"Septic shock","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":7710}]},{"term":"Serratia infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Shigella infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Sinusitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Sinusitis fungal","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Soft tissue infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Staphylococcal infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Subcutaneous abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Subdiaphragmatic abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Superinfection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Testicular abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Toxic shock syndrome","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Tracheobronchitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Tularaemia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Upper respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Upper respiratory tract infection bacterial","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Urethritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":10,"numAffected":10,"numAtRisk":7695},{"groupId":"EG001","numEvents":10,"numAffected":10,"numAtRisk":7710}]},{"term":"Urosepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":7710}]},{"term":"Vestibular neuronitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Viral sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Viral upper respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Visceral leishmaniasis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Wound infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Wound infection pseudomonas","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Wound infection staphylococcal","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Accident","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Acetabulum fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Anastomotic leak","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Aneurysm perforation","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Ankle fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":7,"numAtRisk":7695},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":7710}]},{"term":"Burns second degree","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Burns third degree","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Cataract operation complication","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Chemical poisoning","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Chest injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Clavicle fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Comminuted fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Concussion","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Contusion","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Craniocerebral injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Electrical burn","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Eye penetration","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Facial bones fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Fall","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Femoral neck fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":7695},{"groupId":"EG001","numEvents":5,"numAffected":4,"numAtRisk":7710}]},{"term":"Femur fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":7,"numAtRisk":7695},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":7710}]},{"term":"Fibula fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Flail chest","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Foot fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Forearm fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Fractured sacrum","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Gun shot wound","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Hand fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Head injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":7710}]},{"term":"Hip fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":7710}]},{"term":"Humerus fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Incarcerated incisional hernia","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Incisional hernia","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Joint dislocation","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Joint injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Laceration","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":7710}]},{"term":"Ligament rupture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Ligament sprain","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Limb injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Lower limb fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":7710}]},{"term":"Lumbar vertebral fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Meniscus injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Multiple fractures","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Multiple injuries","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":7710}]},{"term":"Muscle rupture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Muscle strain","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Nerve root injury cervical","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Open fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Overdose","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Patella fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Pelvic fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Pneumothorax traumatic","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Poisoning","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Post procedural haemorrhage","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Procedural pain","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Pubis fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Radius fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":7,"numAtRisk":7695},{"groupId":"EG001","numEvents":7,"numAffected":7,"numAtRisk":7710}]},{"term":"Respiratory fume inhalation disorder","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Rib fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Road traffic accident","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":7710}]},{"term":"Seroma","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Skin abrasion","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Skull fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Snake bite","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Soft tissue injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Spinal compression fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Spinal cord injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Spinal fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Splenic rupture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Sternal fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Subdural haematoma","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Spinal cord injury cervical","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Subdural haemorrhage","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Tendon injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Tendon rupture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Tibia fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Toxicity to various agents","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Traumatic intracranial haemorrhage","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Traumatic shock","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Ulna fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Upper limb fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Vascular pseudoaneurysm ruptured","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Wound","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Wound dehiscence","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Wrist fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Anticoagulation drug level above therapeutic","organSystem":"Investigations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Blood heavy metal increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Haemoglobin decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Decreased appetite","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Dehydration","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Diabetes mellitus","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Diabetes mellitus inadequate control","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Diabetic ketoacidosis","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Electrolyte imbalance","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Gout","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Hyperammonaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Hyperglycaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Hyperkalaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Hyperlipidaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Hypertriglyceridaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Hypoglycaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Hypokalaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Hyponatraemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Ketoacidosis","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Malnutrition","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Metabolic acidosis","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Obesity","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Type 1 diabetes mellitus","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Type 2 diabetes mellitus","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":7710}]},{"term":"Arthritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Arthropathy","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Back pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Costochondritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Fasciitis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Foot deformity","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Intervertebral disc degeneration","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Intervertebral disc disorder","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Intervertebral disc protrusion","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":7,"numAffected":7,"numAtRisk":7710}]},{"term":"Joint destruction","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Lumbar spinal stenosis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Muscle spasms","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Musculoskeletal chest pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Musculoskeletal pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Myalgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Neck pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Osteitis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Osteoarthritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":8,"numAffected":8,"numAtRisk":7695},{"groupId":"EG001","numEvents":11,"numAffected":11,"numAtRisk":7710}]},{"term":"Osteochondrosis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Osteolysis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Osteonecrosis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Periarthritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Polyarthritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Polymyalgia rheumatica","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Rhabdomyolysis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Rheumatoid arthritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Rotator cuff syndrome","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Soft tissue mass","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Spinal column stenosis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Spinal disorder","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Spinal osteoarthritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":7710}]},{"term":"Spondylolisthesis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Still's disease adult onset","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Synovial cyst","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Systemic lupus erythematosus","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Tendonitis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Abdominal neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Acute leukaemia","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Acute myeloid leukaemia","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Acute promyelocytic leukaemia","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Adenocarcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Adenocarcinoma gastric","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Adenocarcinoma of colon","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Adenocarcinoma pancreas","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Adult t-cell lymphoma/leukaemia","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Angioimmunoblastic t-cell lymphoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Basal cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Benign neoplasm of bladder","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Benign neoplasm of orbit","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Benign neoplasm of thyroid gland","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Benign renal neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Benign soft tissue neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Bile duct adenocarcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Bile duct cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Bladder cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":7710}]},{"term":"Bladder neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":7710}]},{"term":"Bowen's disease","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Brain cancer metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Brain neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Brain neoplasm malignant","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Breast cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":8,"numAffected":8,"numAtRisk":7695},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":7710}]},{"term":"Breast cancer female","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Breast cancer in situ","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Breast cancer metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Bronchial carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Bronchial neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Carcinoid tumour of the small bowel","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Cervix carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Cervix carcinoma recurrent","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Cholangiocarcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":7710}]},{"term":"Chronic lymphocytic leukaemia","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Chronic myeloid leukaemia","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Colon adenoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Colon cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":7,"numAtRisk":7695},{"groupId":"EG001","numEvents":11,"numAffected":11,"numAtRisk":7710}]},{"term":"Diffuse large b-cell lymphoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Endometrial adenocarcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Extranodal marginal zone b-cell lymphoma (malt type)","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Fallopian tube cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Gallbladder cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Gastric cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":7695},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":7710}]},{"term":"Gastrointestinal neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Gastrointestinal stromal tumour","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Glioblastoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Glioblastoma multiforme","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Glioma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Glomus tumour","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Hepatic cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Hepatic cancer metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Hepatic neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Hepatocellular carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Hypopharyngeal cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Intraductal proliferative breast lesion","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Invasive ductal breast carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":7695},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":7710}]},{"term":"Invasive papillary breast carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Laryngeal cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Laryngeal neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Leukaemia","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Lip and/or oral cavity cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Lip squamous cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Lipoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Lung adenocarcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":7695},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":7710}]},{"term":"Lung adenocarcinoma metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Lung adenocarcinoma stage i","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Lung cancer metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Lung neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Lung neoplasm malignant","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":11,"numAffected":11,"numAtRisk":7695},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":7710}]},{"term":"Lymphoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":7710}]},{"term":"Malignant melanoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Malignant neoplasm of pleura metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Malignant neoplasm of unknown primary site","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Malignant pleural effusion","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Melanocytic naevus","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Meningioma benign","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Metastases to central nervous system","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Metastases to liver","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":7710}]},{"term":"Metastases to lung","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":7710}]},{"term":"Metastases to lymph","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Metastases to peritoneum","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Metastases to pleura","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Metastasis","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Metastatic carcinoma of the bladder","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Metastatic malignant melanoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Metastatic neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Metastatic squamous cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Nasopharyngeal cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Neoplasm malignant","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Neoplasm skin","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Neuroendocrine carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Non-small cell lung cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Oesophageal adenocarcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Oesophageal carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Oesophageal squamous cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Ovarian cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Ovarian fibroma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Ovarian neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Pancreatic carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":7695},{"groupId":"EG001","numEvents":9,"numAffected":8,"numAtRisk":7710}]},{"term":"Pancreatic carcinoma metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Pancreatic neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Phaeochromocytoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Plasma cell myeloma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Pleural mesothelioma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Prostate cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":7,"numAtRisk":7695},{"groupId":"EG001","numEvents":9,"numAffected":9,"numAtRisk":7710}]},{"term":"Prostate cancer metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Prostate cancer recurrent","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Prostatic adenoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Rectal adenocarcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Rectal adenoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Rectal cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Renal cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":7710}]},{"term":"Renal cancer metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Renal neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Renal oncocytoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Skin cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Small intestine adenocarcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Spinal cord neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Squamous cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Squamous cell carcinoma of lung","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Squamous cell carcinoma of skin","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Squamous cell carcinoma of the oral cavity","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Testicular neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Thyroid adenoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Thyroid cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Thyroid neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Tongue neoplasm malignant stage unspecified","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Tumour haemorrhage","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Uterine cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Uterine leiomyoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Vulval cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Amyotrophic lateral sclerosis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Aphasia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Basal ganglia haemorrhage","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Basal ganglia infarction","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Brain injury","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Carotid artery disease","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Carotid artery stenosis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Carotid artery thrombosis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Cerebral haemorrhage","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":7710}]},{"term":"Cerebral infarction","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":8,"numAffected":8,"numAtRisk":7695},{"groupId":"EG001","numEvents":7,"numAffected":6,"numAtRisk":7710}]},{"term":"Cerebral ischaemia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Cerebrovascular accident","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":19,"numAffected":19,"numAtRisk":7695},{"groupId":"EG001","numEvents":12,"numAffected":12,"numAtRisk":7710}]},{"term":"Cerebrovascular disorder","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Cerebrovascular insufficiency","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Cervicobrachial syndrome","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Chronic inflammatory demyelinating polyradiculoneuropathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Coma","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Dementia alzheimer's type","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Demyelinating polyneuropathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Diabetic neuropathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Dizziness","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":7710}]},{"term":"Encephalopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Epilepsy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":7710}]},{"term":"Generalised tonic-clonic seizure","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Guillain-barre syndrome","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Haemorrhage intracranial","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Haemorrhagic transformation stroke","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Headache","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Hemiparesis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Hydrocephalus","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Hypoaesthesia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Intracranial aneurysm","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Ischaemic stroke","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":7710}]},{"term":"Ivth nerve paralysis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Lacunar infarction","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Loss of consciousness","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Lumbar radiculopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Metabolic encephalopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Migraine","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Mononeuritis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Myasthenia gravis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Myelopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Nerve compression","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Nervous system disorder","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Neuritis cranial","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Paraesthesia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Paraneoplastic neurological syndrome","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Post polio syndrome","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Presyncope","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Radiculopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Reversible ischaemic neurological deficit","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Ruptured cerebral aneurysm","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Sciatica","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Seizure","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":7710}]},{"term":"Spinal claudication","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Subarachnoid haemorrhage","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":7710}]},{"term":"Syncope","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":8,"numAffected":8,"numAtRisk":7695},{"groupId":"EG001","numEvents":8,"numAffected":8,"numAtRisk":7710}]},{"term":"Transient global amnesia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Transient ischaemic attack","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":8,"numAffected":8,"numAtRisk":7695},{"groupId":"EG001","numEvents":7,"numAffected":6,"numAtRisk":7710}]},{"term":"Trigeminal neuralgia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Vascular encephalopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Vasculitis cerebral","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Viith nerve paralysis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Abnormal behaviour","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Adjustment disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Completed suicide","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":7695},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":7710}]},{"term":"Delirium","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Delirium febrile","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Depression","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":7710}]},{"term":"Generalised anxiety disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Korsakoff's syndrome","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Major depression","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Mental status changes","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Psychotic disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":7710}]},{"term":"Somatoform disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Suicidal ideation","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Suicide attempt","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Acute kidney injury","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":8,"numAffected":8,"numAtRisk":7695},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":7710}]},{"term":"Azotaemia","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Bladder prolapse","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Calculus bladder","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Calculus ureteric","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Calculus urinary","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Chronic kidney disease","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":7710}]},{"term":"Diabetic nephropathy","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Haematuria","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Nephrolithiasis","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Renal artery arteriosclerosis","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Renal artery occlusion","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Renal colic","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Renal cyst","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Renal failure","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":7710}]},{"term":"Renal impairment","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Stress urinary incontinence","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Tubulointerstitial nephritis","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Urethral polyp","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Urinary incontinence","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Urinary retention","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":7710}]},{"term":"Benign prostatic hyperplasia","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Cystocele","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Endometrial hypertrophy","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Fibrocystic breast disease","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Ovarian cyst","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Postmenopausal haemorrhage","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Prostatitis","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Prostatomegaly","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Rectocele","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Uterine enlargement","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Uterine prolapse","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Uterovaginal prolapse","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Acute pulmonary oedema","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Acute respiratory failure","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":7710}]},{"term":"Aspiration","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Asthma","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":7695},{"groupId":"EG001","numEvents":7,"numAffected":5,"numAtRisk":7710}]},{"term":"Bronchiectasis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Bronchitis chronic","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Chronic obstructive pulmonary disease","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":9,"numAffected":8,"numAtRisk":7695},{"groupId":"EG001","numEvents":10,"numAffected":8,"numAtRisk":7710}]},{"term":"Dyspnoea","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Emphysema","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Epistaxis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Haemoptysis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Hypoxia","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Idiopathic pulmonary fibrosis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Lung disorder","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Nasal polyps","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Nasal septum deviation","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Nasal turbinate hypertrophy","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Paranasal cyst","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Pickwickian syndrome","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Pleural calcification","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Pleural effusion","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":7710}]},{"term":"Pleurisy","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Pneumonia aspiration","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":7710}]},{"term":"Pneumothorax","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Pulmonary bulla","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Pulmonary congestion","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Pulmonary embolism","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":7695},{"groupId":"EG001","numEvents":13,"numAffected":13,"numAtRisk":7710}]},{"term":"Pulmonary fibrosis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Pulmonary oedema","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Respiratory acidosis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Respiratory arrest","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Respiratory distress","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Respiratory failure","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":7,"numAtRisk":7695},{"groupId":"EG001","numEvents":12,"numAffected":12,"numAtRisk":7710}]},{"term":"Sleep apnoea syndrome","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Decubitus ulcer","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Dermal cyst","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Dermatitis","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Diabetic foot","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Eczema","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Erythema multiforme","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Hyperkeratosis","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Leukoplakia","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Psoriasis","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Skin ulcer","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Cardiac pacemaker replacement","organSystem":"Surgical and medical procedures","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Aneurysm","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Angiodysplasia","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Aortic aneurysm","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":7710}]},{"term":"Aortic dilatation","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Aortic dissection","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Aortic rupture","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Aortic stenosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":7710}]},{"term":"Arterial disorder","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Arterial thrombosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Arteriosclerosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Bleeding varicose vein","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Circulatory collapse","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":7710}]},{"term":"Deep vein thrombosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":7695},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":7710}]},{"term":"Diabetic vascular disorder","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Essential hypertension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Haematoma","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":7710}]},{"term":"Haemodynamic instability","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Haemorrhage","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Hypertension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":8,"numAffected":8,"numAtRisk":7695},{"groupId":"EG001","numEvents":11,"numAffected":10,"numAtRisk":7710}]},{"term":"Hypertensive crisis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":7710}]},{"term":"Hypertensive emergency","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Hypotension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Hypovolaemic shock","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":7710}]},{"term":"Intermittent claudication","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":7710}]},{"term":"Orthostatic hypertension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Orthostatic hypotension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":3,"numAffected":2,"numAtRisk":7710}]},{"term":"Peripheral arterial occlusive disease","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":7710}]},{"term":"Peripheral artery stenosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Peripheral artery thrombosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Peripheral embolism","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Peripheral ischaemia","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Peripheral vascular disorder","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Peripheral venous disease","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Polyarteritis nodosa","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Shock haemorrhagic","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Superior vena cava syndrome","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":7710}]},{"term":"Temporal arteritis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Thrombophlebitis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Varicose ulceration","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":7695},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":7710}]},{"term":"Varicose vein","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":7695},{"groupId":"EG001","numEvents":2,"numAffected":1,"numAtRisk":7710}]}],"otherEvents":[{"term":"Gastrointestinal disorder","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":967,"numAffected":792,"numAtRisk":7695},{"groupId":"EG001","numEvents":449,"numAffected":389,"numAtRisk":7710}]},{"term":"Chills","organSystem":"General disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1860,"numAffected":1464,"numAtRisk":7695},{"groupId":"EG001","numEvents":314,"numAffected":276,"numAtRisk":7710}]},{"term":"Fatigue","organSystem":"General disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3111,"numAffected":2211,"numAtRisk":7695},{"groupId":"EG001","numEvents":961,"numAffected":770,"numAtRisk":7710}]},{"term":"Injection site erythema","organSystem":"General disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":636,"numAffected":493,"numAtRisk":7695},{"groupId":"EG001","numEvents":11,"numAffected":10,"numAtRisk":7710}]},{"term":"Injection site pain","organSystem":"General disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2090,"numAffected":1390,"numAtRisk":7695},{"groupId":"EG001","numEvents":118,"numAffected":104,"numAtRisk":7710}]},{"term":"Injection site swelling","organSystem":"General disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":515,"numAffected":401,"numAtRisk":7695},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":7710}]},{"term":"Pain","organSystem":"General disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6064,"numAffected":3575,"numAtRisk":7695},{"groupId":"EG001","numEvents":627,"numAffected":505,"numAtRisk":7710}]},{"term":"Pyrexia","organSystem":"General disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1839,"numAffected":1498,"numAtRisk":7695},{"groupId":"EG001","numEvents":176,"numAffected":168,"numAtRisk":7710}]},{"term":"Swelling","organSystem":"General disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1573,"numAffected":1154,"numAtRisk":7695},{"groupId":"EG001","numEvents":48,"numAffected":46,"numAtRisk":7710}]},{"term":"Myalgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3234,"numAffected":2277,"numAtRisk":7695},{"groupId":"EG001","numEvents":704,"numAffected":571,"numAtRisk":7710}]},{"term":"Headache","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3044,"numAffected":2167,"numAtRisk":7695},{"groupId":"EG001","numEvents":1198,"numAffected":929,"numAtRisk":7710}]},{"term":"Erythema","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 10.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2408,"numAffected":1690,"numAtRisk":7695},{"groupId":"EG001","numEvents":75,"numAffected":69,"numAtRisk":7710}]}]},"moreInfoModule":{"certainAgreement":{"piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true,"otherDetails":"GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial."},"pointOfContact":{"title":"GSK Response Center","organization":"GlaxoSmithKline","email":"GSKClinicalSupportHD@gsk.com","phone":"866-435-7343"}}},"derivedSection":{"miscInfoModule":{"versionHolder":"2026-11-09"},"conditionBrowseModule":{"meshes":[{"id":"D006562","term":"Herpes Zoster"}],"ancestors":[{"id":"D000073618","term":"Varicella Zoster Virus Infection"},{"id":"D006566","term":"Herpesviridae Infections"},{"id":"D004266","term":"DNA Virus Infections"},{"id":"D014777","term":"Virus Diseases"},{"id":"D007239","term":"Infections"}]}},"hasResults":true}